Podcasts about Dea

Lionel guides listeners through the "last hour of today", delving into the "dark seeming underbelly of a society" during his overnight gig. Lionel offers insights into politics, discussing presidential aspirations—including his own fantasy of abusing the White House kitchen for sandwiches and taking a tour of the White House plates. He also recounts bizarre historical anecdotes, such as the time Richard Nixon impulsively visited protesters at the Lincoln Memorial and the detailed story of Elvis Presley showing up unannounced with a gun to meet President Nixon and receiving a DEA badge. The episode features candid conversations with callers. Lionel explores the concept of what makes a "real honest to God man" and challenges listeners to discover "what the heck is going on here" Learn more about your ad choices. Visit megaphone.fm/adchoices

Running a ketamine clinic? Clinical skills alone won't cut it. You also need to protect your practice from regulatory and financial landmines.In this compilation episode, two experts break down the complex world of DEA compliance and insurance coverage for ketamine clinics. Whether you're about to open your doors or already treating patients, understanding what triggers regulatory scrutiny and how to properly protect your practice isn't optional - it's critical.Our guests reveal the most common mistakes clinics make and share practical strategies to keep your practice safe, compliant, and protected. We've combined insights from two full-length episodes to give you concentrated wisdom on the business foundations every ketamine clinic needs.DISCLAIMER: This episode is for educational and informational purposes only. The views expressed by our guests do not constitute legal, regulatory, or professional insurance advice for your specific practice. Insurance and compliance requirements vary significantly by state and individual circumstances. Always consult with qualified professionals before making decisions for your business or medical practice.Featured ExpertsDennis Wichern - Retired DEA Special Agent in Charge and founder of Prescription Drug Consulting. Dennis spent over three decades with the DEA, including ten years focused specifically on pharmaceutical controlled substance compliance. He now helps healthcare providers understand DEA regulations and maintain proper compliance.Canyon Clifton - CEO of Clifton Insurance Agency, a professional liability and high-risk niche market insurance corporation founded in 1982. Canyon has spent over two decades designing elaborate professional liability and medical malpractice policies for healthcare providers across the US.What You'll Learn in This Episode:・The 3 red flags that trigger DEA audits and how to avoid them・The #1 insurance mistake ketamine clinics make (and how to verify coverage)・Real claims data: What actually happens when things go wrongEpisode 42 show notes:00:00 Teaser - The DEA are Humans too.00:20 Introduction & Episode Overview01:51 Dennis Wichern02:01 The 3 Red Flags That Trigger DEA Audits05:16 State-Level DEA Enforcement Differences08:37 Biannual Inventory Requirements & What to Do If You Missed Them09:39 The DEA's Human Side10:48 Witnessing Requirements for Small Clinics13:47 Canyon Clifton13:57 The #1 Insurance Mistake Ketamine Clinics Make14:59 Where to Find Coverage Details in Your Policy17:03 Why Insurance Applications Matter (They Become Part of Your Policy)18:39 How the Insurance Landscape Has Changed for Ketamine Therapy20:00 Admitted vs. Non-Admitted Insurance Carriers Explained23:29 The Top Insurances Your Ketamine Clinic Needs25:54 Ending & ResourcesThanks for listeningListen to each of their full conversations:Episode 023 - Mastering Clinic Compliance: Insights from Retired DEA Agent Dennis WichernEpisode 034 - Ketamine Clinic Insurance: Expert Insights with Canyon CliftonConnect with the experts:Prescription Drug Consulting WebsiteLinkedInEmail: dennis.wichern@prescriptiondrugconsulting.comPhone: (312) 859-2430Clifton Insurance Agency Website - Mention “Ketamine StartUp” and receive FREE quotes & exclusive policy discounts.Phone: 877-212-4368Clifton Insurance Agency | LinkedInClifton Insurance Agency | Instagram Follow us onLinkedinKetamine StartUp WebsiteYouTube

Can any physician pivot to open a ketamine clinic, and what does it take to do it safely?In this Echo Episode, Dr. Andrea Austin continues her conversation with Dr. Kim Chan Ko, about common questions on ketamine infusions for mood disorders and chronic pain. As an ophthalmologist turned creative director for her emergency physician husband's clinic, Kim shares insights on transitioning careers, required training, and ethical considerations. She discusses building a patient-centered practice, managing risks like emergencies and addiction, and navigating business challenges while prioritizing family and values.You'll hear how they:Clarify licensing and training needs for ketamine clinics, emphasizing specialties like emergency medicine, anesthesia, and psychiatry  Address safety protocols, including emergency preparedness, patient monitoring, and addiction risk management Explore staffing requirements, from nurses to administrative roles, and marketing strategies for attracting patients Inspire physician entrepreneurs with tips on balancing business with personal life, values alignment, and avoiding burnout through intentional pivotsIf you're a physician considering ketamine therapy or entrepreneurial ventures, this episode provides honest FAQs and strategies for ethical, sustainable change.About the Guest“Action brings clarity.” – Dr. Kim Chan koDr. Kim Chan Ko is a board-certified ophthalmologist, diplomat of the American College of Lifestyle Medicine, and co-founder of Ketamine Startup, an online course teaching physicians to open ketamine infusion clinics. After years as creative director of Reset Ketamine in Palm Springs, CA, alongside her emergency physician husband, Kim stepped away from academic ophthalmology to pursue a path aligned with her passions for patient education, mentorship, and innovative healthcare. Her journey through burnout and coaching has shaped her mission to help physicians find clarity and build fulfilling careers.

Rikk and Chris take you deep inside the intense world of DEA and island operations, where every decision could mean life or death. From heart-pounding shootouts to the unseen psychological toll of pulling the trigger, Rikk shares his earliest encounters with violence in law enforcement and the crucial role of agency support after traumatic incidents. The conversation then transports listeners to the island of St. Croix, where the DEA waged war against drug traffickers in daring missions like Operation Limpia Casa and Operation Beach Party. These missions weren't just about chasing cartel leaders—they revealed the ingenuity, grit, and resourcefulness required to outsmart criminals in unpredictable environments.

This week's episode is about the Roman deity Dea Tacita, celebrated with a ritual at the Feralia to keep gossip and the results of "loose tongues" from the family and the city. However, Dea Tacita's origin story relates to a nymph called Lara (also mother of the Lares or household gods), who has her tongue cut out for warning one of Jupiter's would-be paramours of his possibly unwanted advances. This fact makes the symbolism of Dea Tacita a double edged sword--we see the virtues of silence, but is this silence also a type of oppression? 

Today, on Crime & Entertainment, we have Cillian Dunne. Cillian spent several months in Panama living with the infamous dictator Manuel Noriega's right-hand man while writing his book, The Right-Hand Man. Noriega's enforcer was trained by Mossad, the DEA, and Fidel Castro. He's a figure most people have never heard of, despite having an influence in shaping U.S. Cold War policy. While researching the book he also uncovered over 200 classified CIA and DEA documents that will be published for the first time. This is a story about how the CIA develops leaders, uses them, and then discards them. This show will be a banger!!Follow Cillian here:https://www.instagram.com/dunne.cillian?igsh=MXBxdjBhamJpaTRpbg==www.therighthandmanbook.comLinks to Crime & EntertainmentLike us on Facebook -   / crimeandentertainment Follow us on IG -    / crimenentertainment Listen on Spotify - https://open.spotify.com/show/4T67Bs5...Listen on Apple Music - https://podcasts.apple.com/us/podcast...Listen on Stitcher - https://www.stitcher.com/show/crime-e...Listen on Google Podcast - https://podcasts.google.com/feed/aHR0...Listen on Amazon Music - https://music.amazon.com/podcasts/9cd...

Jack McFarland joins Jeff to chat about his journey with the DEA.

Join host Steve Gould on the "Things Police See" podcast as he interviews retired DEA Supervisory Special Agent Jack McFarland. With 32 years of service, Jack shares gripping stories from his time in the Caribbean, tackling drug trafficking, undercover operations, and international law enforcement challenges. From busting offload crews to navigating high-stakes cases in St. Croix and Baltimore, Jack reveals the intense, bizarre, and sometimes humorous moments of his career. Tune in for thrilling tales of DEA operations, Caribbean crime, and the brotherhood of law enforcement. Jack's Instagram - @JackMcFarlandDEA Jack's LinkedIn - @JackMcFarland Truth Social - @JackMcFarlandDEA Website - www.jackmcfarlanddea.com Contact Steve - steve@thingspolicesee.com Support the TPS show by joining the Patreon community today! https://www.patreon.com/user?u=27353055  

Dea-scéala an laghdú ar an ráta cánach do bhialanna a fógraíodh inné sa cháinaisnéis

This week on High Society Radio, Chris Faga and Chris Stanley celebrate the return of Stanningcast and immediately start plotting to get a data center—and maybe a DEA investigation. From “Birds Aren't Real” conspiracies to pro-Israel influencers, the guys unravel internet madness, global comedy fests, and the economics of selling out for $500K. They dig into Rogan rumors, Trump troop talk, and why Churchill might actually have been the villain. By the end, it's Temu time machines, MCU politics, chatbot addicts, and a few bleeps that definitely earned their place.Topics Include:Stanningcast Is Officially BackWe Need a Data CenterCalling the DEAWhere Did “Birds Aren't Real” Come From?No Birds in the PlayoffsTrying to Get $7,000Pro-Israeli InfluencersQatar DispatchRiyadh Comedy Festival HighlightsThe MrBeast & KSI CollabDid Rogan Get an Offer?Stanley Would Do Any Content for $500KHegseth Meeting RecapTrump Talking to the TroopsTemu Time Machine TheoryJulia Louis-Dreyfus: Veep in the MCUTrump's N-Word MomentDuke N-WordemFriend.comAll of Trump's Overreach Came from BidenThe Death of the Nuclear FamilyPeople Addicted to AI ChatbotsBUY OUR NEW SHIRT!https://gasdigitalmerch.com/collections/high-society-radioSupport Our Sponsors!Yo Kratom: ⁠⁠https://yokratom.com/⁠⁠ - Check out Yo Kratom (the home of the $60 kilo) for all your kratom needs!Prize Picks: Visit https://prizepicks.onelink.me/LME0/HSR and use code HSR to get $50 in lineups when you play your first $5 lineup.Fat Dick Hot Chocolate: ⁠⁠https://fatdickhotchocolate.net/⁠⁠ Get you a fat dick at fatdickhotchocolate.netHigh Society Radio is 2 native New Yorkers who started from the bottom and didn't raise up much. That's not the point, if you enjoy a sideways view on technology, current events, or just an in depth analysis of action movies from 2006 this is the show for you.Chris Stanley is the on-air producer for Bennington on Sirius XM.A Twitter Chris Really Likes: ⁠⁠https://x.com/stanman42069⁠⁠Chris from Brooklyn is a lifelong street urchin, a former head chef and current retiree.Twitter: ⁠⁠https://twitter.com/ChrisFromBklyn⁠⁠Engineer: JorgeEditor: TannerInstagram: ⁠⁠https://www.instagram.com/lilkinky69/⁠⁠Executive Producer: Mike HarringtonInstagram: ⁠⁠https://www.instagram.com/themharrington/⁠⁠Twitter: ⁠⁠https://twitter.com/TheMHarrington⁠See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Alan discusses the significant differences between his intensive, abstinence-based path to recovery in 2002 and the current standards of addiction treatment. Prompted by renewing his DEA license and taking a required CE on opiate prescribing, Alan contrasts his successful, disruptive model (therapy and 12-step programs) with the modern focus on Medication-Assisted Treatment (MAT), such as buprenorphine (Suboxone), and harm reduction. He grapples with his past skepticism of these newer methods but shares a patient's story and discusses the Sinclair Method (using naltrexone for alcohol recovery) which have opened his mind to various effective ways of getting well. Alan invites listeners to discuss these evolving approaches in the Very Dental Facebook group and the smaller, recovery-focused group, Dentists That Don't. Some links from the show: Drink Your Way Sober, by Katie Herzog The Sinclair Method Join the Very Dental Facebook group using the password "Timmerman," Hornbrook," "Gary," "McWethy," "Papa Randy" or "Lipscomb!" The Very Dental Podcast network is and will remain free to download. If you'd like to support the shows you love at Very Dental then show a little love to the people that support us! -- Crazy Dental has everything you need from cotton rolls to equipment and everything in between and the best prices you'll find anywhere! If you head over to verydentalpodcast.com/crazy and use coupon code “VERYDENTAL10” you'll get another 10% off your order! Go save yourself some money and support the show all at the same time! -- The Wonderist Agency is basically a one stop shop for marketing your practice and your brand. From logo redesign to a full service marketing plan, the folks at Wonderist have you covered! Go check them out at verydentalpodcast.com/wonderist! -- Enova Illumination makes the very best in loupes and headlights, including their new ergonomic angled prism loupes! They also distribute loupe mounted cameras and even the amazing line of Zumax microscopes! If you want to help out the podcast while upping your magnification and headlight game, you need to head over to verydentalpodcast.com/enova to see their whole line of products! -- CAD-Ray offers the best service on a wide variety of digital scanners, printers, mills and even  their very own browser based design software, Clinux! CAD-Ray has been a huge supporter of the Very Dental Podcast Network and I can tell you that you'll get no better service on everything digital dentistry than the folks from CAD-Ray. Go check them out at verydentalpodcast.com/CADRay!

Episode #408: “There is no way to tell the story of Myanmar and where it's headed if you are leaving out the Wa,” says Patrick Winn, a veteran Southeast Asia reporter and author of Narcotopia. His book traces the wild story how Wa State, a mountainous enclave on the Chinese border, became defined by narcotics, and how it has become one of the key powers in the country today. A pivotal figure is Saw Lu, born in the mid-1940s, raised among Baptist missionaries, and convinced that literacy and Christianity could unify and “civilize” the Wa. Recruited by Burmese intelligence in his twenties, he was sent to Pang Wai, one of the largest Wa strongholds, as a teacher. Winning villagers' trust, he then stumbled on a small CIA weapons cache. Through charisma and tactical skill, he transformed himself into a militia leader. Meanwhile, Kuomintang exiles who had fled China's civil war turned to opium trafficking, industrializing heroin production along the Thai-Burma border. The CIA and Taiwanese intelligence viewed these warlords as useful anti-communist allies, even as their heroin flowed into South Vietnam and fueled American soldiers' addictions. Saw Lu tolerated the opium trade, which he despised, to keep Wa villages united against Maoist influence. At one point, the U.S. even used him as a DEA asset, code-named “Superstar.” In the late 1960s, the Communist Party of Burma controlled much of Wa territory for twenty years, during which time Saw Lu faded into obscurity. But a mutiny of Wa soldiers eventually kicked out the Maoists and birthed the United Wa State Army (UWSA). With Chinese backing and drug profits as their main source of income, the UWSA grew into Myanmar's most powerful non-state military. Saw Lu returned to the scene, and for a while his anti-drug zeal offered a different path to Wa leaders. He wanted to get significant U.S. investment in Wa State in exchange for helping it destroy the drug trade. In the end, however, the CIA undermined Saw Lu's plans, and he was disgraced. Today, Wa State is a “narcostate,” effectively an unrecognized country, a state within a state, stable within its own borders yet destabilizing to Myanmar's unity. “If you think it's just some dark, out of the way place that doesn't matter, please update your thinking on this,” Winn warns.

Ricardo Morales, Jr. joins us LIVE tonight to talk about his new book and his father, the infamous Ricardo "Monkey" Morales. The legend of Cuban exile turned US government operative Ricardo Morales Navarrete has been known in espionage circles for decades. Dubbed “The Monkey” for his disruptive and unpredictable escapades, Morales grabbed headlines for decades as tales of his bombings, arrests, assassination attempts (both those he executed and those he suffered), and testimony constructed a real-life spy adventure unlike anything brought to page or screen. His story delves into diverse aspects of American history, including our nation's conflict with Cuba, our anti-communism military support overseas, JFK's story before and after the Bay of Pigs, Operation 40, and the explosion of the illegal narcotics industry in 1970s Miami. Morales was a contract agent for the CIA and a valuable asset for the FBI; he even shared how he'd met Lee Harvey Oswald at a CIA camp in Florida before JFK's assassination. Morales's counterintelligence skills-for-hire were also a prized utility for Cuban drug kingpins in Miami, many of whom were discarded ex-CIA operatives.Buy the book - https://a.co/d/1XnkG0jWebsite - https://monkeymorales.comThe Coldest Cup - http://snwbl.io/TLG10Silk City Hot Sauce - https://silkcityhotsauce.com Use our code GUNMAN for 20% off entire order at checkout.Cousin Emily's Channel - https://www.youtube.com/@emilyseverything1465Music By - Lee Harold OswaldA Loose Moose ProductionBBB&JOEBBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-lone-gunman-podcast-jfk-assassination--1181353/support.

Ken's Life Story about becoming a smuggler and then working for the DEA.⁣ ⁣ Ken's Book https://www.amazon.com/One-Step-Over-Line-Confessions-ebook/dp/B0CNWH4JR4⁣ ⁣

Gear up, truth seekers—@intheMatrixxx and @shadygrooove, the fearless frontline warriors of The MG Show, storm into Season 7, Episode 188, “Trump's Shutdown Checkmate: Draining the Swamp with Pink Slips and Program Cuts,” airing October 2, 2025, at 12:05 PM Eastern, blending razor-sharp takedowns of government waste with unfiltered fire on foreign meddling and crime-crushing initiatives. Kicking off with tech glitches sorted—Shady's headphone woes fixed and notes locked in—they dive straight into Florida's fiscal revolution, spotlighting Governor Ron DeSantis's blueprint for slashing a billion bucks in county bloat via FAFO audits, from runaway debt to tax relief that keeps the Sunshine State AAA-rated and a beacon for nationwide reform. Shifting to the Big Apple chaos, they dissect socialist Zohran Mamdani's poll surge in the NYC mayoral race, slamming potential billionaire backers from abroad via shadowy 501c4s and drawing parallels to London's woke mayor, warning of Democratic infiltration that's anything but homegrown. Then it's Stephen Miller's Memphis masterplan stealing the show—a full-throttle federal blitz with ATF, DEA, FBI, and ICE unleashing unlimited support to smash urban crime syndicates, hailed as the blueprint to reclaim American streets from chaos. No holding back on the shutdown spotlight, where Trump's vow to wield pink slips and axe wasteful projects turns gridlock into gold, echoing DeSantis's playbook while media hacks spin panic over "essential" pork. They don't spare the influencers either, blasting the so-called Flynn network and military-industrial shields for peddling misinformation, urging patriots to ditch the echo chamber for independent grit amid 501c4 foreign cash floods warping elections. Wrapping with a swift shutdown of Charlie Kirk conspiracy nonsense—Huckabee's nod to his Israel stance seals it—and a fiery roast of Maxine Waters' push for illegal immigrant healthcare as a blatant vote-rig scheme, Jeff and Shannon lay bare the strings pulling the establishment's puppet show. The truth is learned, never told, and the Constitution is your weapon—tune in at noon-0-five Eastern LIVE to stand with Trump! **Keywords** Trump shutdown, DeSantis spending cuts, Florida fiscal reform, Stephen Miller law enforcement, NYC mayoral race, Zohran Mamdani, foreign funding 501c4, media grifters, government waste, Charlie Kirk, Maxine Waters healthcare, MG Show, @intheMatrixxx, @shadygrooove, America First, deep state **Filename** mgshow_s7e188_trumps_shutdown_checkmate_draining_swamp_pink_slips_program_cuts Tune in weekdays at 12pm ET / 9am PST, hosted by @InTheMatrixxx and @Shadygrooove. Catch up on-demand on https://rumble.com/mgshow or via your favorite podcast platform. Where to Watch & Listen Live on https://rumble.com/mgshow https://mgshow.link/redstate X: https://x.com/inthematrixxx Backup: https://kick.com/mgshow PODCASTS: Available on PodBean, Apple, Pandora, and Amazon Music. Search for "MG Show" to listen. Engage with Us Join the conversation on https://t.me/mgshowchannel and participate in live voice chats at https://t.me/MGShow. Social & Support Follow us on X: @intheMatrixxx https://x.com/inthematrixxx @ShadyGrooove https://x.com/shadygrooove Support the show: Fundraiser: https://givesendgo.com/helpmgshow Donate: https://mg.show/support Merch: https://merch.mg.show MyPillow Special: Use code MGSHOW at https://mypillow.com/mgshow for savings! Wanna send crypto? Bitcoin: bc1qtl2mftxzv8cxnzenmpav6t72a95yudtkq9dsuf Ethereum: 0xA11f0d2A68193cC57FAF9787F6Db1d3c98cf0b4D ADA: addr1q9z3urhje7jp2g85m3d4avfegrxapdhp726qpcf7czekeuayrlwx4lrzcfxzvupnlqqjjfl0rw08z0fmgzdk7z4zzgnqujqzsf XLM: GAWJ55N3QFYPFA2IC6HBEQ3OTGJGDG6OMY6RHP4ZIDFJLQPEUS5RAMO7 LTC: ltc1qapwe55ljayyav8hgg2f9dx2y0dxy73u0tya0pu All Links Find everything on https://linktr.ee/mgshow

From the Drug Violence of Miami to Colombia: His DEA Journey to the Cali Cartel. His early start in Law Enforcement was as a part-time police officer on the Jersey Shore, which eventually led to his role in one of the most dangerous assignments in law enforcement history, Chris Feistl's career is a story of grit, perseverance, and determination. His journey took him from the drug violence of Miami to Colombia, where he helped dismantle the infamous Cali Cartel, a saga now immortalized in books, podcasts, and Netflix series like Narcos. Chris Feistl is our guest on the Law Enforcement Talk Radio Show and Podcast, available for free on our website, on Apple Podcasts, Spotify and most podcast platforms. “Miami was chaos during those years,” Feistl recalls. “The violence from the Cocaine Cowboys was unlike anything most Americans could imagine. We were in the middle of a war.” The Law Enforcement Talk Radio Show and Podcast promoted across their Facebook , Instagram , LinkedIn , Medium and other social media platforms. The Cocaine Cowboys Era After joining the DEA following his service as a Virginia Beach police officer, Feistl was assigned to Miami, Florida, ground zero for the cocaine trade in the late 1970s and 1980s. The era was defined by the so-called “Cocaine Cowboys,” traffickers who turned Miami into the epicenter of cocaine smuggling and drug-related violence. Look for supporting stories about this and much more from Law Enforcement Talk Radio Show and Podcast in platforms like Medium , Blogspot and Linkedin . One incident still stands as a symbol of the times. On July 11, 1979, a brazen daytime shootout erupted inside a liquor store at Dadeland Mall. Armed with submachine guns, assailants gunned down rivals in what police described as a “Wild West-style” shootout. Their escape vehicle, later found abandoned, was stocked with weapons and bulletproof vests, earning the nickname “war wagon.” “Miami was the Wild West,” Feistl explains. “Every arrest could turn into a gunfight. That's the environment we lived in daily.” From the Drug Violence of Miami to Colombia: His DEA Journey to the Cali Cartel. Available for free on their website and streaming on Apple Podcasts, Spotify, and other podcast platforms. From Miami to Colombia While in Miami, Feistl's investigations often led back to Colombian suppliers. By the early 1990s, his path took him directly to Colombia itself. Arriving just after Pablo Escobar's death, Feistl shifted focus to the emerging powerhouse of the drug world: the Cali Cartel. “The Cali Cartel was unlike Escobar's Medellín Cartel,” Feistl said. “They operated with a corporate structure, independent cells reporting to managers. It made them more sophisticated and harder to infiltrate.” At the height of its reign between 1993 and 1995, the Cali Cartel controlled more than 80% of the global cocaine market, raking in billions annually. Robert Bonner, former DEA Administrator, once called them “the most powerful criminal organization in the world. No drug organization rivals them today or perhaps any time in history.” The Law Enforcement Talk Radio Show and Podcast episode is available for free on their website , Apple Podcasts , Spotify and most major podcast platforms. Taking Down the Cali Cartel Partnering with fellow DEA agent David Mitchell, Feistl joined a special task force charged with dismantling the cartel. Together, they spent years tracking the cartel's leaders, an effort that culminated in the arrest of the Cali “Godfathers” and the collapse of one of history's most powerful crime syndicates. “Our mission was clear,” Feistl says. “We had to take them down. It wasn't easy, but the Cali Cartel was too big, and too dangerous to continue unchecked.” From the Drug Violence of Miami to Colombia. His success earned him some of the DEA's highest honors, including the Administrator's Award of Honor and multiple Distinguished Service medals from the Colombian government. The full podcast episode is streaming now on Apple Podcasts, Spotify, and across Facebook, Instagram, and LinkedIn. Legacy in Media and Pop Culture Chris Feistl's extraordinary career has been documented across media platforms, ensuring his story reaches far beyond law enforcement circles. He co-authored the book After Escobar: Taking Down the Notorious Cali Godfathers and the Biggest Drug Cartel in History, offering readers a first-hand account of the operations that brought the cartel down. Netflix's hit series Narcos dramatized his work in Season 3, introducing millions of viewers to the complexities of the Cali Cartel. Feistl has also appeared on Drug Lords: The Cali Cartel (Netflix), Narco Wars (National Geographic), Finding Escobar's Millions (Discovery), and German Cocaine Cowboy (Prime Video). His journey and story resonates across Facebook, Instagram, LinkedIn, Apple Podcasts, Spotify, and beyond. Beyond television, he has become a frequent guest on top podcasts including the Law Enforcement Talk Radio Show and Podcast, sharing his expertise on platforms like their website along witt Apple Podcasts, Spotify, and more. He's appeared on This American Life, Game of Crimes, Armchair Expert with Dax Shepard and Monica Padman, and The Adam Carolla Show. On the Law Enforcement Talk Radio Show's Facebook, Instagram, LinkedIn and more fans can continue to follow his journey. From the Drug Violence of Miami to Colombia: His DEA Journey to the Cali Cartel. Looking Back After 26 years with the DEA, 12 of them spent in Colombia, Feistl retired in 2014 as Assistant Special Agent in Charge of the Phoenix Field Division. Looking back, he often reflects on the risks, the victories, and the lives lost along the way. “We were fighting something much bigger than ourselves,” Feistl says. “But if our work saved lives and slowed the violence, then it was worth it.” From the drug violence of Miami to Colombia, Chris Feistl's DEA journey to the Cali Cartel remains one of the most compelling law enforcement stories of modern history. Through books, Netflix, and podcasts, his legacy continues to educate, inspire, and remind the world of the human cost of the global drug trade. Be sure to check out our website . Be sure to follow us on MeWe , X , Instagram , Facebook, Pinterest, Linkedin and other social media platforms for the latest episodes and news. You can help contribute money to make the Gunrunner Movie . The film that Hollywood won't touch. It is about a now Retired Police Officer that was shot 6 times while investigating Gunrunning. He died 3 times during Medical treatment and was resuscitated. You can join the fight by giving a monetary “gift” to help ensure the making of his film at agunrunnerfilm.com . Background song Hurricane is used with permission from the band Dark Horse Flyer. You can contact John J. “Jay” Wiley by email at Jay@letradio.com , or learn more about him on their website . The Law Enforcement Talk Radio Show and Podcast promoted across their Facebook , Instagram , LinkedIn , Medium and other social media platforms. Get the latest news articles, without all the bias and spin, from the Law Enforcement Talk Radio Show and Podcast on Medium , which is free. Find a wide variety of great podcasts online at The Podcast Zone Facebook Page , look for the one with the bright green logo. From the Drug Violence of Miami to Colombia: His DEA Journey to the Cali Cartel. Attributions After Escobar Wikipedia Narcos Netflix All That Is Interesting Wikipedia Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode summary Joe and Mary dive into how platform censorship and shifting algorithms have reshaped psychedelic media, why DoubleBlind moved to a “newsletter-first” model, and what that's revealed about true audience engagement. They reflect on the post-2024 MDMA decision headwinds, state-level policy moves (wins and losses), and how funding, politics, and culture continue to reconfigure the field. They also explore alternatives to alcohol, chronic pain research, reciprocity around iboga/ibogaine, and lessons from PS25 (MAPS' Psychedelic Science 2025). Highlights & themes From platforms to inboxes: Social and search suppression (IG/FB/Google) throttled harm-reduction journalism; DoubleBlind's pivot to email dramatically improved reach and engagement. Post-MDMA decision reality: Investment cooled; Mary frames it as painful but necessary growth—an ecosystem “airing out” rather than a catastrophic pop. Policy pulse: Mixed year—some state measures stalled (e.g., MA), others advanced (e.g., NM; ongoing Colorado process). Rescheduling cannabis may add complexity more than clarity. Censorship paradox: Suppressing education makes use less safe; independent outlets need community support to keep harm-reduction info visible. Chronic pain & long COVID: Emerging overlaps and training efforts (e.g., Psychedelics & Pain communities) point beyond a psychiatry-only frame. Alcohol alternatives: Low-dose or occasional psychedelic use can shift habits for some; Mary stresses individual context and support beyond any single substance. Reciprocity & iboga: Rising interest (including from right-leaning funders) must include Indigenous consultation and fair benefit-sharing; pace of capitalism vs. community care is an active tension. PS25 field notes: Smaller, more manageable vibe than 2023; fewer “gold-rush” expectations; in-person dialogue beats online flame wars. Notable mentions DoubleBlind: Newsletter-first publishing; nurturing new writers and reported stories. Psychedelics & Pain Association / Clusterbusters: Community-driven models informing care and research (cluster headache protocols history). Books & media: Body Autonomy (Synergetic Press anthology); Joanna Kempner's work on cluster headaches - Psychedelic Outlaws; Lucy Walker's forthcoming iboga film. Compounds to watch: LSD (under-studied relative to MDMA), 2C-B, 5-MeO-DMT (synthetic focus), and broader Shulgin-inspired families.   Mary Carreon: [00:00:00] Okay, I'm gonna send it to my dad because he wants to know. Here Joe Moore: we go. Yeah, send it over. So, hi everybody. We're live Joe here with Mary Anne, how you doing today? Mary Carreon: I'm great Joe. How are you? Joe Moore: Lovely. I actually never asked you how to pronounce your last name does say it right? Mary Carreon: Yes, you did. You said it perfectly Joe Moore: lovely. Joe Moore: Um, great. So it's been a bit, um, we are streaming on LinkedIn, YouTube, Twitch X and Kick, I guess. Yeah. Kick meta. Meta doesn't let me play anymore. Um, Mary Carreon: you're in forever. Timeout. I got it. I got it. Yeah. Joe Moore: Yeah. I think they found a post the other day from 2017. They didn't like, I'm like, oh cool. Like neat, you Mary Carreon: know, you know. Mary Carreon: Yeah. That happened to me recently, actually. Uh, I had a post taken down from 2018 about, uh, mushroom gummies and yeah, it was taken down and I have strikes on my account now. So Joe Moore: Do you get the thing where they ask you if you're okay? Mary Carreon: Yes, with, but like with my searches though, [00:01:00] like if I search something or, or someone's account that has, uh, like mushroom or psychedelic or LSD or something in it, they'll be like, mm-hmm are you okay? Mary Carreon: And then it recommends getting help. So Joe Moore: it's like, to be fair, I don't know if I'm okay, but Yeah, you're like, probably not. I don't really want your help. Meta. Yeah. Mary Carreon: You're like, I actually do need help, but not from you. Thanks. Yeah, Joe Moore: yeah, yeah. Mary Carreon: So not from the techno fascists. Joe Moore: Oh, good lord. Yeah. Uh, we'll go there. Joe Moore: I'm sure. Mary Carreon: I know. I just like really dove right there. Sorry. Yeah. All right, so let's, Joe Moore: um, before we go, let's give people like a bit of, you know, high kicks on, on who is Mary, where you working these days and what are you doing? Mary Carreon: Yeah, thank you. My name is Mary Carryon and I am forever and first and foremost a journalist. Mary Carreon: I have been covering, I say the plant legalization spaces for the past decade. It's, it's been nine and a half years. Uh, on January 3rd it will be [00:02:00] 10 years. And I got my start covering cannabis, uh, at OC Weekly. And from there went to High Times, and from there went to Mary Jane, worked for Snoop Dogg. And then, uh, I am now. Mary Carreon: Double blind. And I have become recently, as of this year, the editor in chief of Double Blind, and that's where I have been currently sinking my teeth into everything. So currently, you know, at this moment I'm an editor and I am basically also a curator. So, and, and somebody who is a, uh, I guess an observer of this space more than anything these days. Mary Carreon: Um, I'm not really reporting in the same way that I was. Um, but still I am helping many journalists tell stories and, uh, I feel kind of like a story midwife in many ways. Just like helping people produce stories and get the, get the quotes, get the angles that need to be discussed, get the sentences structures right, and, um, uh, helping [00:03:00] sometimes in a visionary kind of, uh, mindset. Mary Carreon: So yeah, that's what I'm doing these days. Joe Moore: Oh, there it is. Oh, there you are. Love that. And um, you know, it's important to have, um, editors who kind of really get it from a lot of different angles. I love that we have a lot of alignment on this kind of, and the drug war thing and kind of let's, uh, hopefully start developing systems that are for people. Joe Moore: Yeah, absolutely. If you wanna just say that. Yeah, absolutely. Mary Carreon: Yeah, absolutely. Joe Moore: So, um, yeah, I almost 10 years in January. That's great. We um, it's so crazy that it's been that long. I think we just turned nine and a half, so we're maybe just a few, a few months shorter than your I love it. Plant medicine reporting career. Joe Moore: That's great. I love it. Um, yeah, so I think. I think one of the first times we chatted, [00:04:00] um, I think you were doing a piece about two cb Do you, do you have any recollection of doing a piece on two cb? Mary Carreon: I do, yes. Yes. Wait, I also remember hitting you up during an Instagram live and I was like, are you guys taking any writers? Mary Carreon: And you guys were like writers, I mean, maybe depending on the writer. Joe Moore: And I was like, I was like, I dunno how that works. Mary Carreon: Like me. Yeah. Joe Moore: Yeah. It was fun. It was fun to work with people like yourself and like get pieces out there. And eventually we had an awesome editor for a bit and that was, that was really cool to be able to like support young startup writers who have a lot of opinions and a lot of things to point out. Joe Moore: There's so much happening. Um, there was so much fraud in like wave one. Of kind of the psychedelic investment hype. There's still some, but it's lesser. Um, and it's really a fascinating space still. Like changing lives, changing not just lives, right? Like our [00:05:00] perspective towards nearly everything, right? Joe Moore: Yeah. Mary Carreon: Yes, absolutely. Absolutely. I mean, it's interesting because the space has matured. It's evolved. It's different than it was even, what a, I mean, definitely nine years ago, but even five years ago, even four years ago, even last year, things are different. The landscape is different than it was a year ago. Mary Carreon: And I, it's, it's interesting to see the politics of things. It's interesting to see who has money these days given like how hard it is just to kind of survive in this space. And it's interesting just to. Bear witness to all of this going down because it really is a once in a lifetime thing. Nothing is gonna look the same as it does now, as it, uh, then it will like in a, in a year from now or anything. Mary Carreon: So it's really, yeah. It's interesting to take account of all of this Joe Moore: That's so real. Uh, maybe a little [00:06:00] too real, like it's serious because like with everything that's going on from, um, you know, governance, governments, ai Yes. Drug policy shifts. Drug tech shifts, yes. There's so much interesting movement. Um, yes. Joe Moore: You, you know, you, you kind of called it out and I think it's really actually worth discussing here since we're both here on the air together, like this idea that the psychedelic market, not idea, the lived experience of the psychedelic market having shifted substantially. And I, I, I think there's a lot of causes. Joe Moore: But I've never had the opportunity to really chat with you about this kind of like interesting downturn in money flowing into the space. Mm-hmm. Have you thought about it? Like what might the causes be? I'm sure you have. Mary Carreon: Yeah. Yeah, I have. Yeah. I've thought about it. I mean, it's hard. Well, I don't know. I am really not trying to point fingers and that's not what I'm [00:07:00] trying to do here. Mary Carreon: But I mean, I think a lot of people were really hopeful that the FDA decision last June, not last June, the previous June, a year ago, 2024, June was going to open the floodgates in terms of funding, in terms of, um. In terms of mostly funding, but also just greater opportunities for the space and, uh, greater legitimacy granted to the psychedelic medicine space. Mary Carreon: Mm. And for those who might not know what I'm talking about, I'm talking about the, uh, FDA decision to reject, uh, MDMA assisted therapy and, um, that whole, that whole thing that happened, I'm sure if it, you didn't even have to really understand what was going on in order to get wind of that wild situation. Mary Carreon: Um, so, so maybe, yeah. You probably know what I'm talking about, but I, I do think that that had a great impact on this space. Do I think it was detrimental to this space? [00:08:00] I don't think so. We are in a growth spurt, you know, like we are growing and growing pains happen when you are evolving and changing and learning and figuring out the way forward. Mary Carreon: So I think it was kind of a natural process for all of this and. If things had gone forward like while, yeah, there probably would be more money, there would be greater opportunity in this space for people wanting to get in and get jobs and make a living and have a life for themselves in this, in this world. Mary Carreon: I don't know if it was, I don't know if it would necessarily be for the betterment of the space in general for the long term. I think that we do have to go through challenges in order for the best case scenarios to play out in the future, even though that's difficult to say now because so many of us are struggling. Mary Carreon: So, but I, but I have hope and, and that statement is coming from a place of hope for the future of this space and this culture. Joe Moore: Yeah. It's, um, I'm with [00:09:00] you. Like we have to see boom bust cycles. We have to see growth and contraction just like natural ecosystems do. Mary Carreon: Absolutely, absolutely. It has to be that way. Mary Carreon: And if it's not that way, then ifs, if. It's, it like what forms in place of that is a big bubble or like a, a hot air balloon that's inevitably going to pop, which, like, we are kind of experiencing that. But I think that the, I think that the, um, the, the air letting out of the balloon right now is a much softer experience than it would be if everything was just like a green light all the way forward, if that makes sense. Mary Carreon: So, Joe Moore: right. And there's, there's so many factors. Like I'm, I'm thinking about, uh, metas censorship like we were talking about before. Yes. Other big tech censorship, right? Mm-hmm. SEO shifts. Mary Carreon: Oh. Um, yes, absolutely. Also, uh, there were some pretty major initiatives on the state level that did not pass also this past year that really would've also kind of [00:10:00] helped the landscape a little bit. Mary Carreon: Um. In terms of creating jobs, in terms of creating opportunities for funding, in terms of having more, uh, like the perception of safer money flow into the space and that, you know, those, those things didn't happen. For instance, the measure for in Massachusetts that didn't go through and just, you know, other things that didn't happen. Mary Carreon: However, there have been really good things too, in terms of, uh, legalization or various forms of legalization, and that's in New Mexico, so we can't, you know, forget that there, and we also can't forget just the movement happening in Colorado. So there are really great things happening and the, the movement is still moving forward. Mary Carreon: Everything is still going. It's just a little more difficult than maybe it could have been Joe Moore: right. Yeah. Amen. Amen. Yes. But also, we Mary Carreon: can't forget this censorship thing. The censorship thing is a horse shit. Sorry. I'm not sure if I'm allowed to cuss, but it is, [00:11:00] but it is Joe Moore: calling it out and it's important to say this stuff. Joe Moore: And you know, folks, if you want to support independent media, please consider supporting Doubleblind and psychedelics today. From a media perspective, absolutely. We wanna wanna put as much out as we can. Yes. The more supporters we have, the more we can help all of you understand what's happening and yes. Joe Moore: Getting you to stay safer. Mary Carreon: Yeah, absolutely. And that's the whole difficulty with the censorship is that psychedelics today, and Doubleblind for instance, but also Lucid News, also other, uh, other influencers, other creators in the space, they like. What all of us are doing is putting out information that is ultimately creating a safer user experience. Mary Carreon: And so with the censorship, we are not able to do so anymore, which creates actually a lot of danger. So. Yeah, it's, it's difficult. The censorship is difficult, and if you are somebody who posts about psychedelics, I know that you know this and I am preaching to the choir. Joe Moore: Yeah. So can you talk a [00:12:00] little bit about you all at Double Blind made a major shift in the last number of months towards, uh, kind of not necessarily putting everything out there and, and kind of like, um, actually I don't even know the language you use. Joe Moore: What's the, what's the language you use for the kind of model shift you took on? Mary Carreon: Yeah, I mean, it's great. It's been a wild shift. It's been a wild shift. Um, what we are currently doing is we went to a newsletter first model, which instead of just posting onto a website for everyone to see, and then, um, you know, hopefully getting SEO hits and also posting on their, then posting those stories onto Instagram and Facebook and Twitter, and hoping to get traffic through social media. Mary Carreon: Uh, we decided that that was no longer working for us because it wasn't, um, because the censorship is so bad on, on social media, like on Instagram, for instance, and Facebook and Twitter, well, less on Twitter, [00:13:00] but still, nonetheless on social media, the censorship is so bad. And also the censorship exists on Google. Mary Carreon: When you Google search how to take mushrooms, double blinds is not even on. You know, our guide is not on the first page. It's like, you know, way the heck, way the heck down there. Maybe page 2, 3, 4, 5. I don't know. But, um, the issue, the issue with that, or, or the reason why rather that it's that way is because Google is prioritizing, um, like rehabilitation centers for this information. Mary Carreon: And also they are prioritizing, uh, medical information. So, like WebMD for instance. And all of these organizations that Google is now prioritizing are u are, are, are, are organizations that see psychedelic use through the lens of addiction or through drug drug abuse. So [00:14:00] again, you know, I don't know, take it for how you want to, I'm not gonna say, I'm not gonna tell anybody like what is the right way to use their substances or whatever. Mary Carreon: However, it's really important to have the proper harm reduction resources and tools available. Uh, just readily available, not five pages down on a Google search. So anyways, all of that said double blind was our traffic was way down. And it was looking very bleak for a while. Just we were getting kicked off of Instagram. Mary Carreon: We weren't getting any traffic from social media onto our website, onto our stories. It was a, it was a vicious kind of cycle downward, and it wasn't really working. And there was a moment there where Doubleblind almost shut down as a result of these numbers because there's a, like you, a media company cannot sustain itself on really low page views as a result. Mary Carreon: So what we [00:15:00] decided to do was go to a newsletter first model, which relies on our email list. And basically we are sending out newsletters three days a week of new original content, mostly, uh, sometimes on Wednesdays we repost an SEO story or something like that. Um, to just to engage our audience and to work with our audience that way, and to like to actually engage our audience. Mary Carreon: I cannot emphasize that enough because on Instagram and on Facebook, we were only reaching like, I don't know, not that many people, like not that many people at all. And all of that really became obvious as soon as we started sending out to our email list. And as soon as we did that, it was wild. How many, how many views to the website and also how many just open like our open rate and our click through rate were showing how our audience was reacting to our content. Mary Carreon: In other words. [00:16:00] Social media was not a good, in, like, was not a good indicator of how our content was being received at all because people kind of weren't even receiving it. So going to the newsletter first model proved to be very beneficial for us and our numbers. And also just reaching our freaking audience, which we were barely doing, I guess, on social media, which is, which is wild, you know, for, for a, an account that has a lot of followers, I forget at this exact moment, but we have a ton, double blind, has a ton of followers on, on Instagram. Mary Carreon: We were, we, we get like 500 likes or, you know, maybe like. I don't know. If you're not looking at likes and you're looking at views, like sometimes we get like 16 K views, which, you know, seems good, but also compared to the amount of followers who follow us, it's like not really that great. And we're never reaching new, like a new audience. Mary Carreon: We're always reaching the same audience too, [00:17:00] which is interesting because even with our news, with our, with our email list, we are still reaching new people, which is, which says just how much more fluid that space is. Mm-hmm. And it's because it's, because censorship does not at least yet exist in our inboxes. Mary Carreon: And so therefore email is kind of like the underground, if you will, for this kind of content and this type of material journalism, et cetera. So, so yeah. So it, it, it has been a massive shift. It is required a lot of changes over at double blind. Everything has been very intense and crazy, but it has been absolutely worth it, and it's really exciting that we're still here. Mary Carreon: I'm so grateful that Double-Blind is still around, that we are still able to tell stories and that we are still able to work with writers and nurture writers and nurture the storytelling in this space because it needs to evolve just the same way that the industry and the [00:18:00] culture and everything else is evolving. Joe Moore: Yeah, I think, I think you're spot on like the, when I watch our Instagram account, like, um, I haven't seen the number change from 107 K for two years. Mary Carreon: Absolutely. Same. And, um, same. Joe Moore: Yeah. And you know, I think, I think there's certain kinds of content that could do fine. I think, uh, psychedelic attorney, Robert Rush put up a comment, um, in response to Jack Coline's account getting taken down, um, that had some good analysis, um. Joe Moore: Of the situation. Go ahead. You had No, Mary Carreon: no, I'm just like, you know, I can't, when, when journalists are getting kicked off of these, of these platforms for their stories, for their reported stories, that's like, that is a massive red flag. And that's all I have to say. I mean, we could go into more, more details on that, but that is a [00:19:00] huge red flag. Joe Moore: Mm-hmm. Yeah. Um, for sure. The, I, yeah. And like I'm sure he'll get it back. I'm sure that's not for good, but I think he did. Okay, great. Mary Carreon: I think he did. Yeah. Yeah, I think he did. Joe Moore: Yeah. So thank you. Shout out to Jack. Yeah, thanks Jack. Um, and I think, you know, there's, there's no one with that kind of energy out there. Joe Moore: Um, and I'm excited to see what happens over time with him. Yeah. How he'll unfold. Absolutely unfold. Oh yeah. It's like, um. Crushing the beat. Mary Carreon: Oh yeah, absolutely. Especially the political, the political beat. Like, there's no, there's few people who are really tackling that specific sector, which is like mm-hmm. Mary Carreon: So exciting for a journalist. Joe Moore: Yeah. Um, so model shifting, like we all have to like, adapt in new ways. Kyle and I are still trying to figure out what we're gonna do. Like maybe it is newsletter first. Like I, I realized that I hadn't been writing for [00:20:00] years, which is problematic, um, in that like, I have a lot of things to say. Mary Carreon: Totally. Joe Moore: And nobody got to hear it. Um, so I started a substack, which I had complicated feelings about honestly. 'cause it's just another. Rich person's platform that I'm, you know, helping them get Andreessen money or whatever. And, you know, so I'm gonna play lightly there, but I will post here and there. Um, I'm just trying to figure it all out, you know, like I've put up a couple articles like this GLP one and Mushrooms article. Mary Carreon: I saw that. I saw that. Really? And honestly, that's a really, like, it's so weird, but I don't, like, it's such a weird little thing that's happening in the space. I wonder, yeah, I wonder, I wonder how that is going to evolve. It's um, you know, a lot of people, I, I briefly kind of wrote about, um, psychedelics and the GLP, is that what it is? Mary Carreon: GLP one. Joe Moore: GLP one. Say Ozempic. Yeah, just, yeah, Ozempic. Yeah, exactly. Mary Carreon: Yeah, exactly. I wrote about [00:21:00] that briefly last year and there were a bunch of people like obviously horrified, which it is kind of horrifying, but also there's a bunch of people who believe that it is extremely cutting edge, which it also is. Mary Carreon: So it's really interesting, really fascinating. Joe Moore: Yeah. Um, I remember Bernie Sanders saying like, if this drug gets as much traction as it needs to, it will bankrupt Medicaid. I guess that's not really a problem anymore. Um, but, but, uh, but so like naming it real quick, like it changed the way we had to digest things, therefore, like mushrooms get digested differently and, um, some people don't respond in the expected ways. Joe Moore: And then there was some follow up, oh, we, in the regulated model, we just do lemon tech. And then I was like, is that legal in the regulated model? And I, I don't know the answer still. Mm-hmm. Like there was a couple things, you know, if users know to do it, you know, I don't, I don't totally understand the regulated model's so strange in Oregon, Colorado, that like, we really need a couple lawyers opinions. Joe Moore: Right. I think Mary Carreon: yes, of course Joe Moore: the lawyers just gave it a [00:22:00] thumbs up. They didn't even comment on the post, which is, laughs: thanks guys. Um, Joe Moore: but you know, laughs: yeah. You're like, thank you. Joe Moore: Thanks and diversity of opinions. So yeah, there's that. And like GLP ones are so interesting in that they're, one friend reached out and said she's using it in a microdose format for chronic neuroinflammation, which I had never heard of before. Joe Moore: Whoa. And um, I think, you know, articles like that, my intent was to just say, Hey, researchers yet another thing to look at. Like, there's no end to what we need to be looking at. Abso Mary Carreon: Oh, absolutely, absolutely. You know, reporting on this space actually taught me that there's so much just in general that isn't being researched, whether that's in this space, but also beyond and how, um, yeah, just how behind, actually, maybe not, maybe behind isn't the right word, but it kind of feels from my novice and from my novice place in the, in the world and [00:23:00] understanding research, it's. Mary Carreon: Hard for me to see it as anything, but being behind in the research that we all really need, that's really going to benefit humanity. But also, you know, I get that it's because of funding and politics and whatever, whatever, you know, we can go on for days on all of that. Joe Moore: What's the real reason? What's the real reason? Joe Moore: Well, drug war. Mary Carreon: Yeah. Well, yeah, definitely the drug war. Nixon. Yeah. Yes, yes, definitely the drug war. Yeah. I mean, and just the fact that even all of the drug research that happens is, again, through the lens of addiction and drug abuse, so Joe Moore: mm-hmm. Hard to right. Yeah. Um, like ni a is obviously really ridiculous and, and the way they approach this stuff, and Carl Hart illustrates that well, and, Mary Carreon: oh man, yes, he does. Joe Moore: Like, I think Fadiman's lab in Palo Alto got shut down, like 67, 66 or 67, and like that's, you know, that was one of the later ones, Mary Carreon: right? And, Joe Moore: and like, Mary Carreon: and here we are. Joe Moore: The amount of suffering that could have been alleviated if we [00:24:00] had not done this is. Incalculable. Um, yes. Yes. Yeah. Mary Carreon: I mean the, yeah, it's hard to say exactly how specifically it would be different, but it's difficult to also not think that the fentanyl crisis and the opioid addiction rate and situation that is currently like plaguing the, the world, but particularly the United States, it's hard to think that it wouldn't be, like, it wouldn't be a different scenario altogether. Joe Moore: Right, right. Absolutely. Um, and it's, um, it's interesting to speculate about, right? Like Yeah. Yes. Where would we be? And Mary Carreon: I know, I know, I know, I know it is speculation. Absolutely. But it's like hard, as I said, it's hard not to think that things would be different. Joe Moore: Right. Right. Um, I like, there's two kind of quotes, like, um, not, this one's not really a quote. Joe Moore: Like, we haven't really had a [00:25:00] blockbuster psychiatric med since Prozac, and I think that was in the eighties or early nineties, which is terrifying. And then, um, I think this guy's name is James Hillman. He is kinda like a Jungian, um, educator and I think the title of one of his books is, we're a hundred Years Into Psychotherapy and the World is Still a Mess. Joe Moore: And I think like those two things are like, okay, so two different very white people approaches didn't go very far. Yes. Um, yes and laughs: mm-hmm. Joe Moore: Thankfully, I think a lot of people are seeing that. Mm-hmm. Um, finally and kind of putting energy into different ways. Um, Mary Carreon: yeah. Absolutely. I think, yeah, I mean, we need to be exploring the other options at this point because what is currently happening isn't working on many fronts, but including in terms of mental health especially. Mary Carreon: So mm-hmm. We gotta get going. Right? We [00:26:00] gotta get moving. Geez. Joe Moore: Have you all, have you all seen much of the information around chronic pain treatments? Like I'm, I'm a founding board member with the Psychedelics and Pain Association, which has a really fun project. Oh, that's interesting. Mary Carreon: Um, I've seen some of the studies around that and it's endlessly fascinating for obvious, for obvious reasons. Mary Carreon: I, um, we have a writer who's been working for a long time on a story, uh, about the chronic pain that has since. Become an issue for this, for her, for the writer. Mm-hmm. Um, since she had COVID. Mm-hmm. Since, since she is just like, COVID was the onset basically of this chronic pain. And, um, there she attended a psychedelics in pain, chronic pain conference and, uh, that has pretty much like, changed her world. Mary Carreon: Um, well, in terms of just the information that's out there, not necessarily that she's painless, but it's just, you know, offering a, a brand new, a brand new road, a brand new path that is giving her, [00:27:00] um, relief on days when the pain is, uh, substantial. laughs: Yeah. Mary Carreon: So that's interesting. And a lot of people are experiencing that as well. Joe Moore: Mm-hmm. So there's, there's a really cool set of overlap between the COVID researchers, long COVID researchers and the chronic pain people. 'cause there is Yes. This new science of pain that's yes. Our group, PPA put out like a really robust kind of training, um, for clinicians and researchers and even patients to get more educated. Joe Moore: And we're, we're getting, um, kind of boostered by cluster busters and we're kind of leveraging a lot of what they've done. Mary Carreon: Wait, what is a cluster buster? Joe Moore: Oh gosh. Um, so they're a 5 0 1 C3. Okay. Started with Bob Wald. Okay. Bob Wald is a cluster headache survivor. Oh, oh, oh, Mary Carreon: okay. Got it. Got it. Yes. So they're Joe Moore: the charity that, um, has been really championing, um, cluster headache research because they found a protocol [00:28:00] with mushrooms. Joe Moore: Yes, yes, yes. To eliminate. Mm-hmm. Yeah. Um, this really great, I Mary Carreon: love that. Joe Moore: This really great book was written by a Rutgers, um, I think medical sociologist or anthropologist psychedelic. Love laughs: that. Joe Moore: Joanna Kempner. Cool. Um, and it kind of talks about the whole, um, cluster busters saga, and it was, it was pretty cool. Joe Moore: Nice. So they've been at it for about as long as maps. Um, oh wow. Maybe a little earlier. Maybe a little later. Mary Carreon: I love that. Cool. I mean, yeah, that's really great. That's really great. Joe Moore: So we're copying their playbook in a lot of ways and Cool. We about to be our own 5 0 1 C3 and, um, nice. And that should be really fun. Joe Moore: And, uh, the next conference is coming up at the end of next month if people wanna check that out. Psychedelic. Nice. Mary Carreon: Nice, nice, nice. Cool. Joe Moore: Yeah, so that, like, how I leaned into that was not only did I get a lot of help from chronic pain with psychedelics and going to Phish shows and whatever, um, you know, I, and overuse for sure helped me somehow. Joe Moore: [00:29:00] Um, God bless. Yeah. But I, I like it because it breaks us out of the psychiatry only frame for psychedelics. Mm. And starts to make space for other categories. Mm-hmm. Is one of the bigger reasons I like it. Mary Carreon: Mm-hmm. Mm-hmm. Yes. Yes. Which, like, we need to be, we need to, we, no one else is gonna do it for us. We like the people in the space who are finding new uses for these substances need to be creating those, those pathways and those new niches for people to then begin studying, et cetera, and exploring and yeah. Mary Carreon: Making, making a proper avenue for, Joe Moore: right, right. And, you know, um, I don't know that this is a Maha thing, so No, I'm going there, I guess, but like, how do we kind of face squarely America and the world's drinking problems? Not [00:30:00] knowing what we know now about alcohol, you know what I mean? And then like, what are the alternatives? Joe Moore: You know, some, some writers out there on substack are very firm that everybody needs to not do any substance. And like all psychedelics are super bad and drugs are evil, you know, famous sub stackers that I won't name. But you know, like what is the alternative? Like, I, like we have to have something beyond alcohol. Joe Moore: And I think you've found some cannabis helpful for that. Mary Carreon: Yeah, I, you know, it's, it's interesting because it's, there are, there's definitely an argument to be made for the power of these substances in helping, I don't wanna, I don't wanna say curb, but definitely reduce the symptoms of, uh, wanting to use or to drink or to consume a specific substance. Mary Carreon: There's obviously there is an argument to be made. There are, there is ano another camp of people who are kind [00:31:00] of in the, in the, in the, in the realm of using a drug to get off of a drug isn't how you do it. However, and, and I do, it depends on the individual. It depends on the individual and the, and how that person is engaging with their own addiction. Mary Carreon: I think for whether or not the substances work, like whether psychedelics work to help somebody kind of get off of alcohol or get off of cocaine or stop using opioids or, you know, et cetera. Mm-hmm. However, I think like, when the situation is so dire, we need to be trying everything. And if that means, like, if, like, you know, if you look at the studies for like smoking cessation or alcohol use, mushrooms do help, psilocybin does help with that. Mary Carreon: Mm-hmm. But, you know, there's, there's a lot of, there's a lot of things that also need to happen. There's a lot of things that also need to happen in order for those, uh, that relief to maintain and to stick and to, uh, really guide [00:32:00] somebody off of those substances. Mm-hmm. It's not just the substance itself. Joe Moore: Right. So I'm, I'm explicitly talking like recreational alternatives, right. Like how do I Yeah. On per minute, like, am Anitas becoming helpful? Yeah, yeah. Are helpful and Yeah. Yeah. I think like even, um, normal. What we might call like normal American alcohol use. Like Yeah. That's still like, quite carcinogenic and like, um, absolutely. Joe Moore: We're kind of trying to spend less as a country on cancer treatments, which I hope is true. Then how do we, how do we develop things that are, you know, not just abstinence only programs, which we know for sure aren't great. Mary Carreon: Yeah. They don't work. Yeah. I don't, it's, it's difficult. Mm-hmm. It's difficult to say. Mary Carreon: I mean mm-hmm. I don't know. Obviously I, I, well, maybe it's not obvious at all for people who don't know me, but, you know, I exist in a, I exist in, in a world where recreational use is like, it's like hard to define what recreational use is because if we are using this, if we are using mushrooms or LSD even, or MDMA, [00:33:00] you know, there are so many, there's a lot of the therapy that can happen through the use of these substances, even if we're not doing it, you know, with a blindfold on or whatever and yeah, I think like. Mary Carreon: There is a decent swap that can happen if you, if you are somebody who doesn't wanna be, you know, having like three beers a night, or if you are somebody who's like, you know, maybe not trying to have like a bottle of wine at a night or something like that, you know, because like Americans drink a lot and a lot of the way that we drink is, um, you know, like we don't see it as alcoholism. Mary Carreon: Even though it could be, it could be that's like a difficult Joe Moore: potentially subclinical, but right there. Mary Carreon: Um, yeah. Yeah. It's like, you know, it's, um, we don't see it as that because everybody, a lot of people, not everybody, but a lot of people drink like that, if that makes sense. If you know mm-hmm. If you, if you get what I'm, if you get what I'm saying. Mary Carreon: So, you know, I do think that there's a lot of benefit that, I don't [00:34:00] know, having, like a, having a mushroom, having a mushroom experience can really help. Or sometimes even like low dose, low doses of mushrooms can also really help with, like, with the. Desire to reach for a drink. Yeah, totally. And, and AMS as well. Mary Carreon: I know that that's also helping people a lot too. And again, outside of the clinical framework. Joe Moore: Yeah. I'm, a lot of people project on me that I'm just like constantly doing everything all the time and I'm, I'm the most sober I've been since high school. You know, like it's bonkers that like Yeah. Um, and you know, probably the healthiest event since high school too. Joe Moore: Yeah. But it's fa it's fascinating that like, you know, psychedelics kind of helped get here and even if it was like For sure something that didn't look like therapy. Yeah, Mary Carreon: yeah, yeah, yeah. Absolutely. Absolutely. Yeah. I, I think, I think most of us here in this space are getting projected on as to like, you know, being like what Normies would consider druggies or something, or that we are just like, you know, high all the time. Mary Carreon: Um, [00:35:00] I know that that is definitely something that I face regularly, like out in the world. Um, but, you know, I would also, I would also argue that. Uh, like mushrooms have completely altered my approach to health, my approach to mental health, and not even having to consume that, you know, that substance in order or that, you know, that fun fungi, in order for me to like tap into taking care of my mental health or approaching better, uh, food options, et cetera. Mary Carreon: It's kind of like what these, it's like how the mushrooms continue to help you even after you have taken them. Like the messages still keep coming through if you work with them in that capacity. Right. And yeah, and also same with, same with LSD too. LSD has also kind my experiences with that have also guided me towards a healthier path as well. Mary Carreon: I, I understand that maybe for some people it's not that way, but, um, for me that substance is a medicine as well, [00:36:00] or it can be. Joe Moore: Yeah. Um, so. What are, what are some things popping up these days about like US drug policy that's like getting exciting for you? Like, are you feeling feeling like a looming optimism about a, a major shift? Joe Moore: Are you kind of like cautiously optimistic with some of the weird kind of mandatory minimum stuff that's coming up or? Mary Carreon: Yeah. Yeah. I mean, I know that there was a huge, a, a pretty huge shift over at the DEA and I wish I remembered, I wish I remembered his name. The new guy who's now, I believe the head of the DEA, I don't know enough information about it to really feel a way. Mary Carreon: However, I don't think that he's necessarily going to be serving us as a community here, uh, in the psychedelic space. I, you know, I just don't think that that's something that we can ever depend on with the DEA. Uh, I also don't think that [00:37:00] the DEA is necessarily going to be. All that helpful to cannabis, like the cannabis space either. Mary Carreon: Um, I know that, that Trump keeps kind of discussing or, or dangling a carrot around the rescheduling of cannabis. Um, for, he's been, he's been, but he's doing it a lot more now. He's been talking about it more recently. Uh, he says like, in the next like couple weeks that he's going to have some kind of decision around that, allegedly. Mary Carreon: But we will see also, I'm not sure that it's going to necessarily help anybody if we reschedule two. Uh, what from schedule one to schedule th two, three, schedule three. Joe Moore: Either way it's like not that useful. Right. Exactly. Mary Carreon: Yeah. Yeah, exactly. It's, um, just going to probably cause a lot more red tape and a lot of confusion for the state rec markets. Mary Carreon: So it's like something that we, it's like only ridden with unintentional, unintentional consequences. Unintended consequences. Mm-hmm. Because no one knows how it's really going to [00:38:00] impact anything, um, if, if at all. But I don't know. It's hard, it's hard to imagine that there won't be any, uh, like more complex regulatory issues for business owners and also probably consumers as well. Joe Moore: Hmm. Yeah. This guy's name's Terry Cole. Mary Carreon: Oh, the new DEA guy. Joe Moore: Yeah. Um, I don't know much about him. Terry. Yeah. Terry, I would love to chat. Mary Carreon: Yeah. Terry, let's talk. I'm sure your people Joe Moore: are watching. Yeah. So like, just let him know. We wanna chat. Yeah. We'll come to DC and chat it out. Um, yeah. It's, um, but yeah, I, Carl Hart's solution to me makes like almost most of the sense in the world to just end the scheduling system Absolutely. Joe Moore: And start building some sort of infrastructure to keep people safe. That's clearly not what we have today. Mary Carreon: No. But building an infrastructure around the health and wellness and uh, safety of [00:39:00] people is the exact opposite system that we have currently right now. Because also the scheduling system has a lot to do with the incarceration in the United States and the criminal just, or the criminal system. Mary Carreon: So, so yeah, like we can't disentangle the two really. Joe Moore: It just started, um, I feel negligent on this. Uh, synergetic press put out a book like a year or two ago called Body Autonomy. Mm-hmm. Um, did that one come across your desk at all? Mm-hmm. No. I wish basically contributed. Oh, nice. A number of people. So it's both like, um. Joe Moore: Drug policy commentary and then like sex work commentary. Oh, nice. And it was like high level, like love that really, really incredible love that detailed science based conversations, which is not what we have around this. Like, that doesn't make me feel good. So you should go to jail kind of stuff. Or like, I'm gonna humiliate you for real though. Joe Moore: Ticket. Yeah, Mary Carreon: yeah, yeah, yeah, yeah. Oh God. Uh, when you think about it like that, it just really also shows [00:40:00] just the uh, um, the level at which religion has also kind of fundamentally infused itself into the scheduling system, but also our laws, you know, like what you just said, this like, shame-based, I'm going to embarrass you and make you into a criminal when you know actually you are a law for the most part, a law abiding citizen, with the exception of this one thing that you're doing for. Mary Carreon: A, your survival and or your, like, your feeling good, wanting to feel good addressing pain. Um, there's a large, uh, like noise coming out of the front yard of my house right now. Hold on. Just a, it doesn't sound too bad. It doesn't sound too bad. Okay. Okay, good. Not at all. Not at all. Okay. Yeah, I had Joe Moore: people working on my roof all day and somehow it worked out. Joe Moore: Oh, good. Um, yeah. Um, yeah, it's, it's fascinating and I, I've been coming around like, I, I identify as politically confused, [00:41:00] um, and I feel like it's the most honest way I can be. Um, Mary Carreon: I am also politically confused these days, impossible to align with any, uh, party or group currently in existence at this exact juncture in American history. Joe Moore: I can't find any that I want to throw my dice in with. Nah. This idea of like fucking way being. Like what is the most humane way to do government as a way it's been put to me recently. And that's interesting. So it comes down to like coercion, are we caring for people, things like that. And um, I don't think we're doing it in a super humane way right now. Mary Carreon: Um, we, yeah, I am pretty sure that even if there was, I mean, I think that even if we looked at the data, the data would support that we are not doing it in a humane way. Joe Moore: So Mary Carreon: unfortunately, and Joe Moore: you know, this whole tech thing, like the tech oligarch thing, you kind of dropped at the beginning and I think it's worth bringing that back because we're, we're on all [00:42:00] these tech platforms. Joe Moore: Like that's kind of like how we're transmitting it to people who are participating in these other platforms and like, you know, it's not all meta. I did turn on my personal Facebook, so everybody's watching it there. I hope. Um, see if that count gets, Mary Carreon: um, Joe Moore: but you know, this idea that a certain number of private corporations kind of control. Joe Moore: A huge portion of rhetoric. Um, and you know, I think we probably got Whiffs of this when Bezos bought Washington Post and then Yes. You know, Musk with X and like yes. You know, is this kind of a bunch of people who don't necessarily care about this topic and the way we do, and they're like in larger topics too about humane government and like, you know, moving things in good directions. Joe Moore: Um, I don't know, thoughts on that rift there as it relates to anything you, wherever you wanna go. Yeah. Mary Carreon: Yeah. I mean, I don't think that they are looking at, I don't think that they are looking [00:43:00] at it the way that we are. I don't think that they can see it from their vantage point. Um, I think that like, in the, in a similar way that so many CEOs who run businesses have no fucking clue about what's actually happening in their businesses and the actual workers and, and employees of their businesses can tell them in more detail. Mary Carreon: Far more detail about what's actually happening on the, on the floor of their own business. Uh, I think that it is something like that. However, that's not to say that, you know, these, these CEOs who employ people who build the A algorithm are obviously guided to create the limitations on us as people who speak about drugs, et cetera, and are creating a algorithm that ultimately is looking at things in a very blanket way in terms of, uh, like we're probably seen on the same level as like drug dealers, if that makes sense. Mary Carreon: Which is obviously a much, you know, there's, [00:44:00] it's a very different thing. Um, so, you know, there's like these CEOs are giving directions to their employees to ultimately create systems that harm. Information flow and inform and, and like the information health of, of platforms and of just people in general. Mary Carreon: So it's hard to say because there's nuance there, obviously, but I would bet you that someone like Elon Musk doesn't really have a full grasp as to the, the nuances and details of what's even happening within, on the ground floor of his businesses. Because that's like, not how CEOs in America run, run, and operate. Mary Carreon: They're stupid companies. So, so yeah. And I feel like that, like, that's across the board, like that's across the board. That's how I, that's probably how Zuck is operating with Meta and Facebook, et cetera. And yeah, just likewise and across, across the whole, [00:45:00] across the whole spectrum. Joe Moore: Mm-hmm. Yeah. And I think, um, a thing. Joe Moore: Then as the people like, we need to keep looking at how can we keep each other informed. And that's kind of circling back to drug journalism like we do and like, um, other, other sorts of journalism that doesn't really get the press it deserves. Right. And I've been getting far more content that I find more valuable off of tragically back on Zucks platform like IG is getting me so much interesting content from around the world that no major outlet's covering. Mary Carreon: That's so interesting. Like what? Like what would you say? Joe Moore: Oh, um, uh, certain, um, violent situations overseas. Oh, oh, got it. Yeah, yeah, yeah. And, um, you know, that America's paying for, so like, you know, I just don't love that I don't have a good, you know, journalistic source I can [00:46:00] point to, to say, hey, like right. Joe Moore: These writers with names, with addresses, like, and offices here. Yes. You know, they did the work and they're held, you know, they're ethical journalists, so yes. You can trust them. Right. You know what I mean? Yes, Mary Carreon: yes. Yeah, yeah, yeah. I mean, all of this makes everything so much harder for determining, like, the censorship specifically makes it so much harder for the people to determine like, what's real, what's not. Mary Carreon: Because, because of exactly what you just said. Mm-hmm. Like, you know, we are, we are basically what that means, like what is required of the people and people who are consuming information is becoming a smart consumer and being able to determine what's real, what's not. How can we trust this individual? Mary Carreon: How can we not, which isn't analysis process that all of us need to be sharpening every single day, especially with the advent of AI and, uh, how quickly this, this type of content is coming at all of us. Like, especially if you're on TikTok, which many of us are, you know, like information comes flying at you 3000 miles an hour, and it's sometimes [00:47:00] really difficult to determine what's real, what's not, because AI is. Mary Carreon: AI is not where it's going to be, and it still is in its nascent phase. However, it's still pretty fucking good and it's still very confusing on there. So, so again, like the media literacy of the people needs to be sharpened every single day. We cannot be on there, we cannot be on the internet existing. Mary Carreon: That everything that we are seeing is real. Whether that's about, you know, these, um, the violence overseas, uh, happening at the hands of the United States, whether that is, uh, even drug information like, you know, et cetera, all of all of it. Or just like news about something happening at Yellowstone National Park or something that is happening in the, uh, at like. Mary Carreon: Um, like potential riots also happening at protests in downtown la, et cetera. Like all, all of it, we need to be so careful. And I think what that also, like, one way that [00:48:00] we can adjust and begin to develop our media literacy skills is talking to people maybe who are there, reaching out to people who are saying that they were there and asking them questions, and also sussing that out. Mary Carreon: You know, obviously we can't do that for all situations, but definitely some of them. Joe Moore: Yeah, absolutely. Like, Joe Moore: um, a quick pivot. Mm-hmm. Were you at PS 25? Mary Carreon: Yes, I was. What did I think? Uh, you know, I, I was running around like crazy at this one. I felt like I didn't even have a second to breathe and I feel like I didn't even have a second to really see anybody. I was like, worry. I was jumping from one stage to the next. Mary Carreon: However, I would say, uh, one of, one of the things that I have said and how I felt about it was that I felt that this, this event was smaller than it was two years ago. And I preferred that I preferred the reduction in size just because it was, uh, less over, less overwhelming [00:49:00] in an, in an already very overwhelming event. Mary Carreon: Um, but I thought that from the panels that I did see that everyone did a really great job. I thought that maps, you know, it's impressive that maps can put on an event like that. Um, I also was very cognizant that the suits were there in full effect and, uh, you know, but that's not unusual. That's how it was last time as well. Mary Carreon: And, um, I felt that there was Mary Carreon: a, uh, like the, the, the level of excitement and the level of like opportunity and pro, like the prosperous. The like, prospect of prosperity coming down the pipeline like tomorrow, you know, kind of vibe was different than last time. Mm-hmm. Which that was very present at the one, two years ago, uh, which was the last PS psychedelic science. Mary Carreon: Yeah. Um, anyways. Yeah. But it was, you know, it was really nice to see everybody. [00:50:00] I feel like in-person events is a great way for everybody in the psychedelic space to be interacting with each other instead of like keyboard warrioring against each other, you know, uh, over the computer and over the internet. Mary Carreon: I think that, um, yeah, uh, being in person is better than being fighting each other over the internet, so, yeah. Joe Moore: Mm-hmm. People seem to be a little bit more civil in person. Mary Carreon: Exactly. Exactly. Mm-hmm. And I think that that is something that we all need to be considering more often, and also inviting people from across the aisle to your events and creating peace, because in person it's a little different than it is. Mary Carreon: When you have the opportunity to, uh, yeah, like keyboard attack someone over the internet, it's like, yeah. It's just so silly. So silly. We look like fools. Like we look like absolute idiots doing that. And you know what? I cannot sit here and say that I haven't looked like an idiot. So, you know, it's like I'm not, I'm not talking from like a high horse over here, but, but you know, it's like, it's [00:51:00] better when it's in person. Mary Carreon: I feel like there's like more civil engagements that we can all have. Joe Moore: It's practice, you know? Yeah. We're learning. Yeah. We are. We should be learning, including us, and yes, of course. Um, I, I play a subtler game these days and, uh, you know, I, I, I, it's better when we all look a lot better in my opinion, because yes, we can inform policy decisions, we can be the ones helping inform really important things about how these things should get implemented and absolutely right. Joe Moore: Like, Mary Carreon: absolutely. Yeah, it does. It does. Nobody, any service, especially these medicines, especially these sacraments, especially these plants, these molecules, et cetera, if we are all sitting here fighting each other and like calling each other names and trying to dunk on one another, when like in reality, we are also all kind of pushing for the same thing more or less. Joe Moore: Mm-hmm. So a thing that [00:52:00] I, it's a, it's kind of a, I, I had a great time at PS 25. I have no, no real complaints. I just wish I had more time. Yeah, same. Um, same. Yeah. Our booth was so busy. It was so fun. Just good. And it was like, good. I, I know. It was really good. I'm trying to say it out loud. I get to talk at the conference before Rick did. laughs: Oh, oh, Joe Moore: the morning show they put us on at like seven 30 in the morning or something crazy. Oh my god. It was early. I dunno if it was seven 30. Mary Carreon: That's so early. That's so early. Joe Moore: Yeah, right. Like that's crazy. I got zero nightlife in That's okay. Um, I was not, I was there for work. Yeah, Mary Carreon: yeah. I was Joe Moore: jealous. I didn't party, but you know, whatever. Joe Moore: Yeah, yeah. Mary Carreon: I did not party this time really in the same way that I did at PS 20. Was it 2023? Joe Moore: 23, yeah. 23. I only stay up till 11 one night in 23. Nice. Mary Carreon: Okay. Um, okay. Joe Moore: So I behaved, I have a pattern of behaving. 'cause I like That's good. I'm so bent outta shape inside going into these things. I'm like, I know, I know. Joe Moore: And, and I'm like, oh, all [00:53:00] my friends are gonna be there. It's gonna be great. And then it's like, yeah. It's mostly friends and only a little bit of stress. Yeah. Um, yeah. Yeah, Mary Carreon: yeah. I had a, I had a great time. It was really good seeing everybody again. Like you, I wish that I had more time with people. Like there are people that I like didn't even see who are my friends, Joe Moore: so, which Yeah. Joe Moore: Which is sad. That's like a subtext in, in like the notes coming away from 25. Is that the, um, American Right, if we wanna call it that, is very interested in this stuff. Oh yeah. Like the Texas establishment. Oh yeah. Um, the Texas contingent, right? They're deep. They're real deep. Mm-hmm. I have, um, Mary Carreon: let's talk about that more. Mary Carreon: Yeah. So Joe Moore: it's optimistic in, in some sense that psychedelic science is getting funded more. By states. 'cause the feds aren't stepping up. Right. I love that. Right. Yeah. Like, Hey feds, look what we can do. And you can't somehow, and [00:54:00] then, um, we'll see if state rights stays around for a while longer, maybe, maybe not. Joe Moore: And then the other part is like, is there a slippery slope given the rhetoric around addiction and the rise in interest in iboga for compulsory addiction treatment with psychedelics or, or compulsory mental health treatments with psychedelics because of the recent, it's illegal to be a person without housing. Joe Moore: Um, and you're gonna get put in treatment. Mm. Like, that's now a thing. So like, I don't know, I don't think forced treatment's good at all. I, and I don't think like, um, like the data is something like 15% effective, maybe less. Right. Right. It's not a good use of money. I don't know. We're, let's, I. You can go there if you want, and riff on that, or if you wanna talk about like, Texas, um, Arizona more generally. Mary Carreon: Yeah. I mean, I will just say this, I also don't really believe that forced treatment is like good, you [00:55:00] know, data Joe Moore: says it's bad. Mary Carreon: Yeah. Yeah. I also, yeah, I mean, it's like, I don't know. Yeah, that's, it's complex. It's a complex issue. I also don't think it's good, but I also do think that we need a much better framework and foundation for like, if people do want the help, helping them get it. Mary Carreon: Much more easily and in a way that's going to be beneficial for them. Um, and I don't think that that system or that pathway currently exists as we saw in, uh, with, with, um, measure 1 0 9 and the failure of measure 1 0 9 or, or was it Measure 1 0 10, 1 10, measure one 10 in Oregon. Joe Moore: But did you see the response yesterday or two days ago? Joe Moore: No, I didn't. No, I didn't. I'll I'll send it to you later. Okay. So the university did the research, um, Portland State University did the research Yes. And said, Hey, look, there was actually 20 other things that were higher priority. Like that actually influenced this increase in overdoses, not our law. Mary Carreon: Right. Mary Carreon: Yes. It was really COVID for Okay. [00:56:00] Like for, yeah. Right. Absolutely. Also, there was not a. Like there was not a framework in place that allowed people to get off the street should they want to, or you know, like, like you just can't really have a, all drugs are legal, or small amounts of drugs are legal without also offering or creating a structure for people to get help. Mary Carreon: That, that's, you can't do one without the other. Unfortunately. That's just like a, that's faulty from the start. So that's all I'll really say about that. And I don't think that that had fully been implemented yet, even though it was something that wasn't ideal for the, um, for the, for the measure. And I believe it was measure one 10, not measure 1 0 9, to be clear. Mary Carreon: Measure one 10. Um, yes, but confirmed one 10 confirmed one 10, yes. Mm-hmm. Um, but yeah, uh, that's, you know, that's kind of what I'll say. That's what I'll, that's where I'll leave that portion. Mm-hmm. You know? Uh, but yeah, forced treatment. I don't know. [00:57:00] We can't be forcing, forcing people to do stuff like that. Mary Carreon: I don't know. It's not gonna, it's, yeah, it doesn't seem Joe Moore: very humane. Mary Carreon: Yeah. No. And it also probably isn't gonna work, so, Joe Moore: right. Like, if we're being conservative with money, like, I like tote, like to put on Republican boots once in a while and say like, what does this feel like? And then say like, okay, if we're trying to spend money smartly, like where do we actually get where we want to be? Joe Moore: And then sometimes I put on my cross and I'm like, okay, if I'm trying to be Christian, like where is the most, like, what is the most Christian behavior here in terms of like, what would the, you know, buddy Jesus want to do? And I'm just like, okay, cool. Like, that doesn't seem right. Like those things don't seem to align. Joe Moore: And when we can find like compassionate and efficient things, like isn't that the path? Um, Mary Carreon: compassionate and t. Yeah, even, I don't know, I don't know if it looks lefty these days, but Yeah, I know what you mean. Yeah, I know what you mean. I know what you mean. Yeah. [00:58:00] Yeah. Um, yeah, it's complicated. It's complicated, you know, but going back, kind of, kind of pivoting and going back to what you were talking about in regards to the subtext, some of the subtext of like, you know, where psychedelic medicine is currently getting its most funding. Mary Carreon: You know, I do believe that that was an undercurrent at psychedelic science. It was the, the iboga conversation. And there's, there's a lot, there's a lot happening with the Iboga conversation and the Iboga conversation and, um, I am really trying to be open to listening to everyone's messages that are currently involved in. Mary Carreon: That rise of that medicine right now? Um, obviously, yeah, we will see, we'll see how it goes. There's obviously a lot of people who believe that this is not the right move, uh, just because there's been no discussions with, uh, the Wii people of West Africa and, you know, because of [00:59:00] that, like we are not talking to the indigenous people about how we are using their medicine, um, or medicine that does like that comes from, that comes from Africa. Mary Carreon: Um, also with that, I know that there is a massive just devastating opioid crisis here that we need to do something about and drug crisis that we need to be helping with. And this medicine is something that can really, really, really help. Um, I find it absolutely fascinating that the right is the most interested party in moving all of this forward, like psychedelic medicine forward. Mary Carreon: And I, I currently have my popcorn and I am watching and I am eating it, and I am going to witness whatever goes down. Um, but I'm, I, I hope that, uh, things are moving in a way that is going to be beneficial for the people and also not completely leave behind the indigenous communities where this medicine comes from. Joe Moore: [01:00:00] Mm-hmm. Mary Carreon: We'll see how it goes. Yeah. We'll see how it goes. We'll see how it goes. It Joe Moore: would be lovely if we can figure it out. Um, I know, and I think, uh, Lucy Walker has a film coming out on Iboga. Mm. I got to see it at Aspen, um, symposium last summer, and it was really good. Mm. So I'm sure it'll be cut different, but it's so good and it tells that story. Joe Moore: Okay. Um, in a helpful way. I'm gonna, I, yeah. I always say I'm gonna do this. I'm like, if I have space, maybe I'll be able to email her and see if we can screen it in Colorado. But it's like a brilliant film. Yeah. Cool. This whole reciprocity conversation is interesting and challenging. And so challenging being one of the few countries that did not sign onto the Nagoya protocol. Joe Moore: Absolutely. We're not legally bound, you know, some countries are Mary Carreon: I know. Yes, yes, yes. So Joe Moore: we're, you know, how do we do that? How do we do that skillfully? We still haven't done it with, um, first Nations folks around their [01:01:00] substances. Um, I think mushrooms are a little flexible and account of them being global, um, from Africa to Ireland and beyond. Joe Moore: And, but you know, that's, we still want to give a nod to the people in Mexico for sure. Yeah, absolutely. Absolutely. Yeah. Um, yeah. Yeah, it's, I had some fun commentary there that I would love to flesh out someday. Uh, but yeah, it's not for today. Mary Carreon: Yeah, yeah, yeah. Um, there's, yeah, there's obviously, there's obviously a lot with the conversation of reciprocity here and, um, I know, I, I don't know. Mary Carreon: I, I, what I do know is that we need to be listening to the indigenous people, not just listening to them second, like secondhand or listening to them, uh, once we have moved something forward, like actually consulting with them as the process goes. And that, you know, the way that both parties move, indigenous folks and, uh, western folks move, uh, are at inherently different paces. Mary Carreon: And, [01:02:00] um, I just hope, and I wish, and I, I hope, I just hope that, uh, Western what, like the Western party, the western folks who are diving into these medicines. Slow the fuck down and listen and just are able to at least make one right move. Just one, just like you. Like it's, doesn't have to be this, it doesn't have to be that hard. Mary Carreon: Although the pace of capitalism usually propels, uh, the western folks at, at a much quicker rate than, u

Sabrena Collins had what most people would call a good upbringing — but by 13 years old, she was already hooked on meth. After getting sober once, a painful divorce sent her spiraling back into addiction and deeper into the drug world. What started as using turned into selling, and one night a police chase changed everything — ending with Sabrena being shot in the head by law enforcement. Instead of ending there, things got worse. Sabrena was charged by the DEA in a federal drug conspiracy case for trafficking meth and was sentenced to 9 years in federal prison. #ShotInTheHead #PoliceShootings #PrisonStory #TrueCrimePodcast #PrisonDocumentary #SurvivalStory #PrisonInterview #lockedinpodcast Connect with Sabrena Collins: Tiktok@ sabrenamorgan Facebook @ Sabrena Morgan Insta @thesabrenamorgan YouTube @thesabrenamorgan Www.transformingcriminaljustice.com Hosted, Executive Produced & Edited By Ian Bick: https://www.instagram.com/ian_bick/?hl=en https://ianbick.com/ Presented by Tyson 2.0 & Wooooo Energy: https://tyson20.com/ https://woooooenergy.com/ Use code LOCKEDIN for 20% OFF Wooooo Energy Buy Merch: http://www.ianbick.com/shop Timestamps: 00:00 Shot in the Head & 9 Years in Prison: Meet Sabrina Collins 02:00 Growing Up in Kansas City & Family Life 06:00 Struggling with Body Dysmorphia & Diet Pills at a Young Age 08:30 Turning to Meth & Living a Double Life 13:00 Hiding Addiction from Family & Excelling in School 18:00 College Years, Quitting Meth & Big Life Choices 22:00 Marriage, Motherhood & Becoming a Real Estate Agent 27:00 Divorce, Custody Battles & Emotional Collapse 36:00 Relapse, Drug Dealing & Mental Health Spiral 41:00 High-Speed Chase & Getting Shot by Police 47:00 DEA Investigation & Federal Arrest 51:00 Indictment & The Moment Everything Changed 54:00 Pre-Trial Rehab: Getting Clean Before Prison 59:00 Sentenced to 9 Years in Federal Prison 01:04:00 Prison Life: Survival, Growth & Finding Purpose 01:12:00 Halfway House & Home Confinement Challenges 01:18:00 Becoming an Advocate & Rebuilding Her Life 01:23:00 Early Clemency: The Day She Walked Free 01:27:00 Life After Prison: Adjusting to Freedom 01:33:00 TikTok, Community & Helping Other Women 01:39:00 What the Prison System Gets Wrong & Needs to Fix 01:45:00 Nonprofit Work, Advocacy & Fighting for Change 01:51:00 Advice to Her 13-Year-Old Self & Final Thoughts Learn more about your ad choices. Visit megaphone.fm/adchoices

Hoy en Me Lo Dijo Adela, platicamos con el Dr. David Pérez Esparza, académico, consultor y ex funcionario del Gobierno de México, quien estuvo con Celorio para analizar la llamada “Misión Cortafuegos”. En este contexto, México y Estados Unidos firmaron un acuerdo histórico para frenar el tráfico de armas, mientras la DEA anunció la detención de 670 personas ligadas al CJNG en EE.UU. entre el 22 y el 26 de septiembre, lo que plantea la pregunta: ¿compromiso real o discurso político? Adela Micha moderó la mesa de análisis con Damián Zepeda (ex dirigente nacional del PAN), Arturo Ávila (diputado federal de Morena) y Juan Zavala (diputado federal de MC y representante ante el INE), debatiendo los temas más candentes, incluyendo los pagos millonarios de Adán Augusto López, la negociación México–EE.UU. para frenar el tráfico de armas, el primer año de Sheinbaum en la presidencia y la polémica reforma de amparo. Más adelante, se conversó con Antonio Juárez Navarro, especialista en derecho penal, penalista que ha protegido por más de 20 años a los Ángeles Blancos y se ha consolidado como figura clave en la defensa legal del gremio médico, siendo recientemente reconocido con el premio Outstanding Contribution to Medical Human Rights & Legal Defense Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This Day in Legal History: Woodrow Wilson Supports Women's SuffrageOn September 30, 1918, President Woodrow Wilson took the unprecedented step of addressing the U.S. Senate directly to urge passage of a constitutional amendment guaranteeing women the right to vote. The House of Representatives had already approved the amendment earlier that year, but the measure had stalled in the Senate. Wilson's speech came during the final months of World War I, a context he used strategically—arguing that women had proven their patriotism and value to the nation through their labor, sacrifice, and civic contributions during wartime.Framing suffrage as a war measure and an issue of national unity, Wilson stated that denying women the vote was an injustice that undermined American democratic ideals. He contended that the world was watching and that the U.S. could not claim to fight for democracy abroad while denying it to half its citizens at home. The speech was notable both for its timing and for the fact that it came from a president who had previously been lukewarm on the issue.Wilson's appeal was a calculated political move, reflecting both the growing power of the women's suffrage movement and the need to maintain national morale. Though his speech failed to immediately sway enough senators—the amendment would not pass the Senate until June 1919—it marked a pivotal shift in executive support. Wilson's endorsement helped legitimize the movement and apply pressure on reluctant lawmakers.The Nineteenth Amendment, which prohibited the denial of the right to vote on the basis of sex, was finally ratified in August 1920. Wilson's 1918 address thus stands as a key moment in the long legal and political battle for women's suffrage in the United States, symbolizing the growing alignment of public sentiment, executive advocacy, and legislative momentum that would eventually culminate in constitutional change.In an exclusive from Reuters, federal drug prosecutions in the United States have dropped to their lowest level in decades, as the Trump administration shifts law enforcement priorities toward immigration enforcement. A Reuters analysis of nearly 2 million federal court records reveals that prosecutions for drug offenses are down 10% from the same period in 2024, with money laundering charges—often linked to high-level traffickers—dropping by 24%. These declines mark the slowest rate of federal drug enforcement activity since at least the late 1990s.The shift stems from President Trump's directive shortly after taking office to reallocate thousands of federal agents toward immigration-related efforts, including assisting U.S. Immigration and Customs Enforcement (ICE) in daily raids. This redirection of resources has disrupted traditional drug enforcement operations, with agents reporting that long-term investigations have stalled and critical cases are going “stagnant.” Even fentanyl-related investigations have been sidelined due to agents being pulled into immigration duties.Despite promises of a tough-on-drugs approach—including calls for the death penalty for some dealers—the administration's actions have hollowed out the Justice Department's Organized Crime Drug Enforcement Task Force and rerouted DEA and ATF agents to support deportation operations. These agents, often unfamiliar with immigration law, are now tasked with support roles such as transportation and crowd control during raids, sometimes simply for the sake of producing social media-friendly imagery.Meanwhile, prosecutions tied to drug importation and conspiracies have declined 6% and 15%, respectively, and gun charges associated with drug crimes have also fallen. Officials warn that the impact of this reprioritization could deepen over time, as investigations delayed today will not yield prosecutions for months or years. Nearly half of all federal criminal charges this year involve immigration violations, and over 700 federal prosecutors have been reassigned to immigration matters.While the White House defends the shift as a successful effort to reduce the flow of drugs by targeting violent criminals and cartels, law enforcement officials describe a chaotic, politically driven enforcement regime that sacrifices complex criminal investigations for visible, short-term wins. The resulting system raises concerns not only about public safety but about the long-term effectiveness of federal law enforcement priorities.Exclusive: Federal drug prosecutions fall to lowest level in decades as Trump shifts focus to deportations | ReutersThe Pentagon has deployed 200 Oregon National Guard troops under federal authority after President Donald Trump announced plans to send military forces into Portland, Oregon. The move, aimed at protecting federal immigration facilities from what Trump called “domestic terrorists,” immediately triggered a legal challenge from the state. Oregon Attorney General Dan Rayfield filed a federal lawsuit against Trump, Defense Secretary Pete Hegseth, and Homeland Security Secretary Kristi Noem, arguing that the federal deployment infringes on the state's sovereign authority over its own law enforcement and National Guard.The lawsuit describes Trump's justification as exaggerated and unsupported, noting that protests against ICE in Portland have remained relatively small and peaceful since June. It also highlights a sharp decline in violent crime in the city—homicides are reportedly down 51% compared to the same time last year—raising further questions about the necessity of military intervention.The deployment order took even top Pentagon officials by surprise, with several describing it as a “bolt from the blue.” Defense Secretary Hegseth's memo authorizing the deployment was later attached as evidence in Oregon's lawsuit. Portland officials, including Mayor Keith Wilson, were not informed of the plan in advance and reportedly learned about it via social media.Trump's rhetoric about using “full force” remains ambiguous, with no clarification on whether that includes authorization of lethal force or under what conditions it could be used. Historically, U.S. troops deployed domestically are only permitted to use force in self-defense. The sudden move has heightened tensions, particularly following a recent shooting at an ICE facility in Dallas that left one detainee dead and two others injured. Critics argue the administration's increasingly aggressive immigration enforcement risks politicizing the military and provoking unnecessary conflict in U.S. cities.Pentagon calls up 200 National Guard troops after Trump Portland announcement | ReutersIn my column for Bloomberg this week, I explore a recent tariff investigation. The investigation into computer peripheral manufacturer Anker Innovations' alleged tariff evasion highlights how modern tariff enforcement has evolved into a sprawling, bureaucratic effort that diverts taxpayer resources toward compliance rather than bolstering domestic industry. Rather than serving as effective tools of economic nationalism, tariffs often end up creating work for customs officials, trade lawyers, and compliance consultants. Each adjustment to tariff classifications triggers complex administrative networks that contradict the ideal of limited government.This system's irony deepens when considering that agencies like the IRS are underfunded, even as policymakers lean more on tariffs—a less efficient and more easily manipulated revenue source. The result is a compliance-heavy environment that benefits well-resourced firms while leaving smaller importers at a disadvantage. Investigating potential violations can be costly and time-consuming, encouraging selective enforcement and fostering a procedural limbo where discretion and inefficiency thrive.The current approach, which places tariff power largely in the executive branch, introduces volatility and undermines predictability in trade policy. Companies may invest heavily in litigation over classification issues, only to see the rules change mid-process. This undermines confidence in the system and raises the risk of corruption and favoritism. I argue that returning tariff authority to Congress and reinvigorating corporate tax enforcement would make the system more equitable and effective. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.minimumcomp.com/subscribe

Hoy en Me Lo Dijo Adela, platicamos con el Dr. David Pérez Esparza, académico, consultor y ex funcionario del Gobierno de México, quien estuvo con Celorio para analizar la llamada “Misión Cortafuegos”. En este contexto, México y Estados Unidos firmaron un acuerdo histórico para frenar el tráfico de armas, mientras la DEA anunció la detención de 670 personas ligadas al CJNG en EE.UU. entre el 22 y el 26 de septiembre, lo que plantea la pregunta: ¿compromiso real o discurso político? Adela Micha moderó la mesa de análisis con Damián Zepeda (ex dirigente nacional del PAN), Arturo Ávila (diputado federal de Morena) y Juan Zavala (diputado federal de MC y representante ante el INE), debatiendo los temas más candentes, incluyendo los pagos millonarios de Adán Augusto López, la negociación México–EE.UU. para frenar el tráfico de armas, el primer año de Sheinbaum en la presidencia y la polémica reforma de amparo. Más adelante, se conversó con Antonio Juárez Navarro, especialista en derecho penal, penalista que ha protegido por más de 20 años a los Ángeles Blancos y se ha consolidado como figura clave en la defensa legal del gremio médico, siendo recientemente reconocido con el premio Outstanding Contribution to Medical Human Rights & Legal Defense Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Gobierno mexicano reporta afectación de 706 mdp al crimen organizado  Detectan fuga de aguas negras en el Bordo de Xochiaca tras lluvias  Los conejos no son roedores, sino lagomorfos, aquí te contamosMás información en nuestro podcast

Send us a textThe morning the DEA walked into a small Charleston clinic, a life split in two. One moment a respected physician, the next a number, a cell, and a label that would follow forever. What unfolded after the raid wasn't a neat comeback—it was cold floors, no visitors, and a verse on loop: “Be anxious for nothing.” And from that stripped place, a different kind of story took root.We sit with a raw account of shock, shame, and the slow work of grace. You'll hear about the Christian group that showed up with toiletries, the radio sermon that landed like a lifeline, and the hard decision to keep living when despair felt easier. We talk plainly about what a felony changes—travel bans, lost rights, doors that stay closed—and what it doesn't: the capacity to love, to learn, to serve without applause. Along the way, we widen the lens to the “but God” pattern pulsing through Scripture—the wine gone at Cana, the empty baskets before thousands, the Red Sea at their backs, the tomb sealed shut—moments where human effort ends and mercy begins.From there, we turn to love as first principle. Not sentiment, but a way of moving through the world when fear and rejection press in. We unpack how love makes the other virtues possible, why obedience isn't wasted even when it's refused, and how joy and humor are not escapes from pain but signs that healing is taking hold. The conversation is honest, warm, and unscripted—part testimony, part teaching, part family table. If you've ever felt defined by your worst day, or wondered where God is when the bottom falls out, this one is for you.Subscribe, share with someone who needs hope, and leave a review with your own “but God” moment—we'd love to hear it.Support the show

Ryan Wrecker and Dan Buck host a packed Marc Cox Morning Show covering politics, culture, and local news. Hour 1 looks at the federal budget, the James Comey indictment, a major DEA bust tied to cartels in St. Louis, and in Buck Don't Give a ____ features Lex Renick's story of transgender regret and detransitioning. Hour 2 highlights school safety, UN speeches by Volodymyr Zelensky and Donald Trump, TikTok regulation with Eben Brown, sports updates, and “In Other News” with a stolen penguin statue and quirky headlines. Hour 3 includes Eugene Kontorovich on UN politics, Israel, and UK free speech, Capitol Beat with Rep. Dr. Bob Onder on a potential government shutdown and Medicaid reforms, and another Buck Don't Give a ____ on cultural pressures around gender surgeries. Hour 4 spotlights maternity leave, TikTok security, retail crime, and political speculation, followed by the Queen of Hearts drawing benefiting the St. Louis BackStoppers, and Nicolee Ambrose on political violence, youth attitudes, and free speech after the assassination of Charlie Kirk.

Ryan Wrecker and Dan Buck open Hour 1 with the federal budget, the James Comey indictment, and a major DEA bust tied to cartels in St. Louis. They compare Trump vs. Biden law enforcement, discuss Christianity's role in the Constitution with Milo Yiannopoulos's speech, and in Buck Don't Give a ____ hear Lex Renick's story of transgender regret and detransitioning. The hour closes with debate on California's new “hate speech” law and comparisons to the UK and Canada.

Habitantes de Lerma bloquean la México-Toluca en protesta por inundaciones Adán Augusto reconoce que no repetiría nombramiento de Hernán BermúdezDEA emite ficha de búsqueda contra el Mayito FlacoMás información en nuestro podcast

In this episode, Justin sits down with Chad, a family nurse practitioner and military veteran with nearly a decade of experience in pain management. Chad is ready to break free from the “golden handcuffs” of his current role to launch a men's health practice focused on testosterone replacement therapy, peptides, weight loss, and PRP treatments. His goal? To create a niche practice tailored to dads, veterans, and first responders.They explore the challenges of entering a saturated men's health market, the pros and cons of telemedicine versus a brick-and-mortar setup, and the importance of standing out in a competitive space. Justin shares why having a physical office can boost credibility and patient acquisition, while also offering practical advice on navigating licensing, DEA requirements, and non-competes. They also discuss creative ways to market a telemedicine practice, from leveraging local communities to building an online presence.If you're dreaming of starting your own niche clinic but feel stuck in a secure job, this episode is packed with actionable insights to help you take the leap with confidence.

Episode 208 - Sept. 25th, 2025 - 2 on 2 For The Better  - Violations Counter - ZERO featuring @DJIntence & @Walt1090  - John Legend - The Life Of DJ Intence & Walt1090  - Big Daddy Kane & The Influence of Big Daddy Kane  - Hip-Hop Stories  - Jimmy Kimmel Story  - @djintence Financies Woes & Good Vibes  - Druski Skits (Coulda Find Love 2)  - Cardi B. “Am I The Drama” Numbers Recap & Album Review  - Taylor Swift vs Cardi B. Double standard  - Kehlani recent MUSIC run  - Dame Dash Drama Update - Federal Judge Rules that DEA must pay Legal Fees for man that had his money Confiscated at Atlanta Airport  - John Oliver “Last Week Tonight” - https://www.youtube.com/watch?v=3kEpZWGgJks - Man jumps overboard a Royal Caribbean Cruise to avoid a $16k Gambling & Room Fees  - A New Jersey woman admits to fraud on Social Security Benefits  - A Middle School Student is arrested for Sextortion Scheme  - Chicago Teen Ambushed & Died for Designer Shoes  - 50 Cent talking about Knowing Your Surroundings  - Recap of @Walt1090's Taylor Swift “September” Cover by @adivunsolicited & @whoisadiv  - Wise Guy's Corner - Judge rules that Mother must pay back Child Support for a father for overpaying child support  - Wise Guy's Corner - A Man is mad at his Girlfriend for cheating on him, even tho he's well ENDOWED  - Wise Guy's Corner - @Walt1090 disgust for the phrase “Girl, I'll Drink Your Bath Water” 

DEA agents seized 50,208 counterfeit M30 pills in Centralia that tested positive for carfentanil, a synthetic opioid 100 times more potent than fentanyl. The seizure highlights the deadly threat fueling the opioid epidemic in Washington state and beyond. https://www.clarkcountytoday.com/news/thousands-of-counterfeit-m30-pills-containing-carfentanil-seized-in-centralia/ #WashingtonState #Centralia #DEA #Carfentanil #OpioidEpidemic #OverdoseCrisis #SyntheticOpioids #PublicSafety

Australia no solo presenta uno de los consumos más altos de drogas ilegales per cápita en el mundo, sino que también se ha detectado últimamente que grupos de crimen organizado transnacional provenientes de Latinoamérica ya están operando en nuestro territorio, según la DEA y la ACIC.

Familiares de desaparecidos de Ayotzinapa protestan en Iguala, Guerrero Alito Moreno denuncia ante el FBI y la DEA a Adán Augusto López Trump demuestra su apoyo a la reelección de Milei en Argentina 

This is a rebroadcast of ep. 119In this episode of Libertarians Talk Psychology, we dive into the Netflix series Narcos and connect its gritty storytelling to America's decades-long War on Drugs. While Narcos shows the DEA and U.S. forces hunting down Colombian drug lords, the real question is whether U.S. policy fueled the very chaos it claimed to fight. Was the United States truly protecting its citizens, or did political interests, corruption, and unintended consequences make the situation worse?We explore how prohibition, black markets, and government intervention shaped the rise of cartels, and what psychology tells us about power, control, and human behavior in this so-called “war.” This conversation challenges mainstream narratives and asks listeners to think critically about history, politics, and the human cost of the War on Drugs.Clip Used: Narcos, season 3, episode 10Follow Us:YouTubeTwitterFacebookBlueskyAll audio & videos edited by: Jay Prescott Videography

On this episode of the South Carolina Lede for September 23, 2025: we look at the abrupt removal of the state election commission director Howard Knapp; we get an update on illicit drug trends in the state from the DEA; we also have some new polling on the governor's race; and more!

The Sinaloa Cartel is unraveling—its leaders captured, its factions at war, and U.S. pressure at an all-time high. Yet in Nogales, Sonora, one of Mexico's most strategic border plazas, business continues as usual. In this episode, we travel to Nogales to uncover: -How the Chapitos betrayed El Mayo Zambada with the DEA's help -Why Nogales is vital for drug and human smuggling routes into the U.S. -First-hand accounts from locals and former smugglers inside cartel operations -The rise of retail drug markets (“tiendas”) across Mexico -How cartels enforce their own version of “law and order” in border towns From bloody betrayals in Culiacán to quiet cartel control in Nogales, this story reveals the new face of Mexico's underworld. Today's Episode Is #Sponsored By The Following: PrizePicks! Visit https://prizepicks.onelink.me/LME0/CONNECT and use code CONNECT and get $50 in lineups when you play your first $5 lineup! Ava! Take control of your credit right now. Download the Ava app today, and when you join using promo code CONNECT20, you'll save 20% for your first year—monthly or annual, your choice. FRE! Get 20% off you first order at https://frepouch.com using code CONNECT at checkout! Join The Patreon For Bonus Content! https://www.patreon.com/theconnectshow 00:00 Sinaloa Cartel in Crisis 02:03 Chaos and Violence in Culiacán 04:08 How Drug Trafficking Has Changed 05:24 Nogales: A Key Border Plaza 06:15 The Mechanics of Smuggling 08:17 This Episode Is Sponsored By PrizePicks and Ava! 11:31 Why Nogales Matters 13:01 Inside the World of a Cartel Operator 16:04 This Episode Is Sponsored By FRE 18:27 Cartel Evolution and Internal Rivalries 22:31 US Pressure and Crackdowns on Corruption 26:10 Retail Drug Markets in Mexico 30:05 Different Cartel Rules for Drugs 31:48 Cartel Justice and Crime in Nogales 33:24 Low-Key Tension on the Border 35:35 Why Locals Don't Break Away 36:19 Impunity and the Limits of Law Enforcement 37:12 What Really Matters in the Drug War 38:53 The Future of the Sinaloa Cartel 39:05 Closing Thoughts & Outro Learn more about your ad choices. Visit podcastchoices.com/adchoices

Episode 206 of the What Are We Doing podcast is stacked, babes. This week I'm back with a fresh nose piercing, courtesy of a throwback prom fundraiser for breast cancer research. Fifty bucks, one piercing, and apparently I've advanced science by a decade. You're welcome.From there, we break open the wildest headline of 2025: Taylor Swift arrested on weapons and drug charges after a standoff on her tour bus. Yes, you heard that right. Submachine guns, meth, fentanyl, explosives—the whole DEA starter pack. Is it a setup by Scooter Braun? Was it Travis Kelce with the diamond playbook? I lay out the only logical defense strategy.Then we roll straight into late-night chaos. Jimmy Kimmel got yanked off ABC after Sinclair flexed their conservative media monopoly muscles. Fallon cracked a bad joke. Colbert pretended to care. And the whole thing proves once again that freedom of speech doesn't mean what you think it does when billionaires run TV.Meanwhile, Trump's busy bragging about his $250 million White House ballroom like it's a new Bass Pro Shop, and I'm praying aliens blow the roof off 20 minutes after the first dinner service. Jimmy Kimmel is out, Charlie Kirk's assassination fallout continues, and somehow librarians in Pennsylvania are now part of the culture war. What are we doing?And just when you thought you could breathe—Dunkin Donuts decided to double the points needed for a free iced coffee. Nine hundred points. Nine. Hundred. Points. In this economy. We need to rally the Cracker Barrel Army and launch a full-blown digital assault to get those rewards rolled back.Plus, I react to the new Now You See Me 3 trailer, Elon Musk's AI “Grok” Twitter takeover, and why Hollywood thinks dropping ChatGPT references makes movies relevant. Spoiler: it doesn't.It's chaos from start to finish. Grab your Dude Robe (promo code WAWD for 20% off at duderobe.com) and tune in, because this week's episode is a doozy.*************************************************************✅DUDEROBE - PROMO CODE: WAWD 20% OFFhttps://duderobe.com - promo code: WAWD*************************************************************Disclaimer: We at the What are We Doing podcast want to make it clear that the views and opinions expressed in this video belong solely to the speakers or authors and do not represent the views and opinions held by YouTube, its partners, or its owners.We must also emphasize that the information contained in this video has been produced with no warranty, expressed or implied, regarding the validity, accuracy, reliability, completeness, legality, or usefulness of what is said or expressed. Therefore, we strongly advise that no one viewing or listening to this video should rely on the information presented herein.We want to make it clear that the speakers or authors in this video express their views in an "artistic" manner as defined within the YouTube guidelines and that this video is purely for entertainment purposes only.

Episode 203: Microinduction and harm reduction in OUD.  Nathan Bui and Sanjay Reddy describe how to manage opioid use disorder (OUD) by using microinduction and harm reduction, strategies that are reshaping the way we treat opioid use disorder. Written by Sanjay Reddy, OMSIV and Nathan Bui, OMSIV. Western University of Health Sciences, College of Osteopathic Medicine of the Pacific.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.IntroWelcome to episode 203 of Rio Bravo qWeek, your weekly dose of knowledge.Today, we're tackling one of the biggest health challenges of our time: opioid use disorder, or OUD. Nearly every community in America has been touched by it: families, friends, even healthcare providers themselves. For decades, treatment has been surrounded by barriers, painful withdrawals, stigma, and strict rules that often do more harm than good. Too many people who need help never make it past those walls. But here's the hopeful part, new approaches are rewriting the story. They are less about rigid rules and more about meeting people where they are. Two of the most promising strategies for treatment of OUD are buprenorphine microinduction and harm reduction. Let's learn why these two connected strategies could change the future of addiction recovery. Background information of treatment: The X-waiver (short for DATA 2000 waiver) was a special DEA requirement for prescribing buprenorphine for opioid use disorder. Doctors used to take extra training (8 hours) and apply for it. Then, they could prescribe buprenorphine to a very limited number of patients. The X-waiverhelped regulate buprenorphine but also created barriers to access treatment to OUD. It was eliminated in January 2023 and now all clinicians with a standard DEA registration no longer need a waiver to prescribe buprenorphine for OUD. Why buprenorphine?Buprenorphine is one of the safest and most effective medications for opioid use disorder. It has some key attributes that make it both therapeutic and extremely safe: 1) As a partial agonist at mu-opioid receptors, it binds and provides enough partial stimulation to prevent cravings and withdrawal symptoms without producing strong euphoria associated with full agonists. 2) Because it has a strong binding affinity compared to full agonists, it easily displaces other opioids that may be occupying the receptor. 3) As an antagonist at kappa-opioid receptors, it contributes to improved mood and reduced stress-induced cravings. 4) The “ceiling effect”: increasing the dosage past a certain point does not produce a stronger opioid effect. This ceiling effect reduces the risk of respiratory depression and overdose, making it a safer option than full agonists. 5) It also had mild analgesic effects, reducing pain. 6) Long duration of action: The strong binding affinity and slow dissociation from the mu-opioid receptor are responsible for buprenorphine's long half-life of 24–60 hours. This prolonged action allows for once-daily dosing in medication-assisted treatment for OUD. Induction vs microinduction:The problem is, starting it—what's called “induction”—can be really tough. Patients usually need to stop opioids and go through a period of withdrawal first. Drugs like fentanyl, which can cause precipitated withdrawal —a sudden, severe crash may push people back to using opioids. Because buprenorphine binds so tightly to the mu-opioid receptor, it can displace other opioids, such as heroin or methadone. If buprenorphine is taken while a person still has other opioids in their system, it can trigger sudden and severe withdrawal symptoms.Opioid withdrawal sign sand symptoms:Opioid withdrawal symptoms are very uncomfortable; patients may even get aggressive during withdrawals. As a provider, once you meet one of these patients you never forget how uncomfortable and nasty they can be. The symptoms are lacrimation or rhinorrhea, piloerection "goose flesh," myalgia, diarrhea, nausea/vomiting, pupillary dilation, photophobia, insomnia, autonomic hyperactivity (tachypnea, hyperreflexia, tachycardia, sweating, hypertension, hyperthermia), and yawning. Think about all the symptoms you run for COWS (Clinical Opiate Withdrawal Scale). It is estimated 85 % of opioid-using patients who inject drugs (PWID) reported opioid withdrawal. Fortunately, even though opioid withdrawal is very uncomfortable, it is not life-threatening (unlike alcohol or benzodiazepine withdrawal, which can be fatal).Many patients who start the journey treating opioid use disorder experience “bumps in the road” --they avoid treatment or drop out early. What is Microinduction? Microinduction is a fairly new strategy started in Switzerland around 2016. It is also known as the “Bernese method” (named after the city of Bern, Switzerland). With this method, instead of stopping opioids cold turkey, patients start with tiny doses of buprenorphine—fractions of a milligram. These doses gradually increase over several days while the patient continues their regular opioid use. While they begin this titer, they can continue use of the full agonist they were previously using–methadone, fentanyl, or heroin, while the buprenorphine begins to take effect. Once the buprenorphine builds up to a therapeutic level, the full agonist is stopped. This method uses buprenorphine's unique pharmacology to stabilize the brain's opioid system without triggering those really nasty withdrawal symptoms.Early studies and case reports suggest this is safe, tolerable, and effective method to do. Microinduction is changing the game, and it has been spreading quickly in North America. Instead of forcing patients to stop opioids completely, the dose is slowly increased over the next three to seven days, while the patient keeps using their usual opioids.By the end of that week, the buprenorphine has built up to a therapeutic level and the full agonist is stopped. The difference is really dramatic. Instead of a painful crash into withdrawal, patients describe the process as a gentle step down, or a ramp instead of a cliff. It's a flexible method. It can be done in a hospital, a clinic, or even outpatient with good follow-up. Once a patient and doctor develop a strong relationship built on the principles of patient autonomy and patient-centered care, microinduction can be closely monitored on a monthly basis including televisits. Microinduction has been shown to help more patients stay in treatment. The Role of Harm Reduction Instead of demanding perfection, harm reduction focuses on best practices providers can implement to reduce risk and keep patients safe. Harm reduction can vary from providing naloxone to reverse overdoses, giving out clean syringes, or offering safer injection education. It also means allowing patients to stay in treatment even if they keep using other substances, and tailoring care for groups like adolescents, parents, or people recently released from incarceration. Harm reduction says that instead of demanding perfection, let's focus on progress. Instead of all-or-nothing, let's devote resources to keeping people alive and safe. As mentioned,an option is providing naloxone kits so overdoses can be reversed in the moment. Also, giving out clean syringes so the risk of HIV or hepatitis infection is reduced while injecting heroin. Another way to reduce harm is teaching safer injection practices so people can protect themselves until they're ready for that next step in their treatment. It also means keeping the doors open, even when patients slip. If someone is still using other substances, they still deserve care. And it means tailoring support for groups who oftentimes get left behind. For people like adolescents, parents balancing childcare, or people coming out of incarceration who are at the highest risk of overdose. Harm reduction recognizes that recovery isn't a straight line. It's about meeting people where they are and walking with them forward. Conclusion:Microinduction is itself a harm reduction strategy. It lowers barriers by removing the need for painful withdrawal.When paired with a harm reduction culture in clinics, patients are more likely to enter care, stay engaged, and build trust with doctors for continued care. Managing opioid use disorder is one of the greatest health challenges of our time. But solutions like buprenorphine microinduction and harm reduction strategies are reshaping treatment—making it safer, more humane, and more accessible. If we embrace these approaches, we can turn barriers into bridges and help more people find recovery. Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you. Send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Bluthenthal, R. N., Simpson, K., Ceasar, R. C., Zhao, J., Wenger, L., & Kral, A. H. (2020). Opioid withdrawal symptoms, frequency, and pain characteristics as correlates of health risk among people who inject drugs. Drug and Alcohol Dependence, volume 211, 1 June 2020, 107932. https://doi.org/10.1016/j.drugalcdep.2020.107932.De Aquino, J. P., Parida, S., & Sofuoglu, M. (2021). The pharmacology of buprenorphine microinduction for opioid use disorder. Clinical Drug Investigation, 41 (5), 425–436. https://doi.org/10.1007/s40261-021-01032-7. Taylor, J. L., Johnson, S., Cruz, R., Gray, J. R., Schiff, D., & Bagley, S. M. (2021). Integrating harm reduction into outpatient opioid use disorder treatment settings. Journal of General Internal Medicine, 36 (12), 3810–3819. https://doi.org/10.1007/s11606-021-06904-4.Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/. 

Según está consignado en materiales de capacitación de varias agencias del orden, el uso de ciertos emojis estaría relacionado con códigos utilizados por el crimen organizado.En otras noticias: Fuertes enfrentamientos entre autoridades y manifestantes durante una protesta frente al centro de procesamiento de ICE en Broadview, Illinois.El gobierno de Trump le pidió a la Corte Suprema poner fin al TPS para más de 300 mil venezolanos.El nuevo panel de asesores de los CDC se reunió por segundo día consecutivo, limitó la vacuna contra el covid y pospuso su decisión respecto a la vacuna contra la hepatitis B.En medio de los ataques a embarcaciones venezolanas, la DEA habría sugerido ataques militares a narcotraficantes en México.

In this week's BOAT Briefing, online editor Holly Margerrison is joined by news editor Dea Jusufi to unpack the latest from the Cannes Yachting Festival – from the numbers behind the show to the standout yachts that captured attention – before looking ahead to the Monaco Yacht Show 2025. They preview some of the biggest debuts set to hit Port Hercule, from Amels' Energy to Heesen's reimagined Solemates, and discuss the market trends shaping this year's event. Plus, Holly and Dea share their personal highs and lows from the show season so far – including the best canapés spotted dockside. BOAT Pro: https://boatint.com/1s5 Subscribe: https://boatint.com/1s6 Contact us: podcast@boatinternationalmedia.com Links to articles discussed in the show:  Cannes live blog: https://boatint.com/21b Monaco live blog: https://boatint.com/21c Magic yacht report: https://boatint.com/21d Energy yacht report: https://boatint.com/21e Solemates yacht report: https://boatint.com/21f 

Grow your management tools for opioid withdrawal in the hospital. Investigate how to decide between methadone and buprenorphine, additional medications to manage symptoms and how and when to use short-acting opioids for management of withdrawal. We're joined by Ashish Thakrar, MD at the University of Pennsylvania.  Claim CME for this episode at curbsiders.vcuhealth.org! By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education. Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | CME! Show Segments Intro, disclaimer, guest bio Guest one-liner Case from Kashlak; Definitions Symptoms of opioid withdrawal Medications for the management of opioid withdrawal Buprenorphine precipitated withdrawal Starting Buprenorphine: Experiences and Strategies  Titrating Methadone: Dosage and Adjuncts Adjunctive short-acting opioids Emerging Trends in Drug Supply: Xylazine and Medetomidine Outro  Credits Producer, Show Notes: Zina Huxley-Reicher Infographics: Zina Huxley-Reicher MD and Zoya Surani Hosts: Carolyn Chan, MD MHS, Zina Huxley-Reicher MD, Shawn Cohen, MD Reviewer: Payel Jhoom Roy, MD, MSc Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guest: Ashish Thakrar, MD MHSP Sponsor: Mint Mobile  Shop plans at MINTMOBILE.com/CURB Sponsor: Freed Use code: CURB50 to get $50 off your first month when you subscribe! Sponsor: FIGS  We've teamed up with FIGS, and now Curbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX.

In April 2006, 23-year-old Christopher Lampkin was murdered in a Salem apartment, shot execution-style, and dismembered by Leonardo Garcia Gonzalez and Victor Gonzalez. His remains were stuffed into a duffel bag and fed to pigs at a Yamhill County farm, where police later recovered partial remains in a feed barrel. The killers were ordered to pay Lampkin's family $1 million, while charges against the farm owner and apartment complex were ultimately dismissed.https://linktr.ee/UnforbiddentruthBecome a supporter of this podcast: https://www.spreaker.com/podcast/unforbidden-truth--4724561/support.

President Trump is escalating the war on drugs. In addition to the recent strike on an alleged drug-smuggling boat from Venezuela, the administration continues to take aggressive action to curb the flow of illicit drugs and crack down on the gangs trafficking them into the country. Special Agent Frank Tarentino, who is part of the DEA New York Division, joined FOX News Rundown host Dave Anthony to discuss how the DEA is working with the military and other government agencies to help cut off the flow of drugs into the country. Tarentino also discusses the gains they've made in fighting the fentanyl epidemic and outlines the challenges in the war on drugs. We often must cut interviews short during the week, but we thought you might like to hear the full interview. Today on Fox News Rundown Extra, we will share our entire interview with DEA Special Agent Frank Tarentino, as he explains how the drug trade operates and how he and others are working to stop it. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In this episode of The President's Daily Brief: The Gaza war spreads to the Gulf, where Israel has targeted Hamas leaders in Qatar—one of the key nations involved in mediating a potential ceasefire. Over 600 suspected members of the Sinaloa Cartel are behind bars tonight after a nationwide DEA operation. North Korea claims a breakthrough in its missile program, with Kim Jong Un personally overseeing the test of a new ICBM rocket engine that puts the U.S. mainland in range. And in today's Back of the Brief—an explosion aboard Greta Thunberg's Gaza flotilla sparks claims of a drone attack, but Tunisian officials investigating the incident are telling a different story. To listen to the show ad-free, become a premium member of The President's Daily Brief by visiting PDBPremium.com.Please remember to subscribe if you enjoyed this episode of The President's Daily Brief.YouTube: youtube.com/@presidentsdailybrief TriTails Premium Beef: Reclaim dinner from the jaws of school-year chaos Visit https://trybeef.com/PDB. BRUNT Workwear: Get $10 Off at BRUNT with code PDB at https://www.bruntworkwear.com/PDB #Bruntpod American Financing: NMLS 182334, nmlsconsumeraccess.org. APR for rates in the 5s start at 6.327% for well qualified borrowers. Call 866-885-1881 for details about credit costs and terms. Visit http://www.AmericanFinancing.net/PDB. Learn more about your ad choices. Visit megaphone.fm/adchoices

Murph continues his powerful conversation with retired DEA Special Agent David Tyree, diving deeper into the human side of law enforcement and the international fight against drug trafficking. David reflects on the importance of children, family, and community in shaping the legacy of law enforcement. He shares stories from his time in Portugal, where international teamwork and financial investigations played a crucial role in dismantling powerful drug trafficking networks. With raw honesty, David emphasizes the role of mentorship, leadership, and self-regulation within the DEA, highlighting how these values not only guide agents but also protect communities worldwide.

In this high-yield episode of Curbsiders Addiction Medicine, we dive deep into a practical and compassionate approach to caring for patients using methamphetamines and/or living with methamphetamine use disorder. We explore the latest pharmacologic options, harm reduction strategies, contingency management, and innovative ideas for monitoring and supporting patients. Whether you're in primary care or other subspecialty settings, this episode is packed with pearls for every clinician with our amazing guest, Dr. Phillip Coffin, Director of the Center on Substance Use and Health in the SFDPH.  Claim CME for this episode at curbsiders.vcuhealth.org! By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education. Episodes | Subscribe | Spotify | iTunes | CurbsidersAddictionMed@gmail.com | CME! Credits Producer/Script Writer/Show Notes: Era Kryzhanovskaya, MD Infographic and Cover Art: Zoya Surani Hosts: Carolyn Chan, MD. MHS and Era Kryzhanovskaya, MD Reviewer: Sarah Leyde MD Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guest: Dr. Phillip Coffin Show Segments Intro, disclaimer, guest bio Guest one-liner Case from Kashlak; Definitions Four-tier approach to taking care of patients with methamphetamine use/use disorder Medications for treatment Psychosocial treatment Harm reduction New horizons in treatment  Outro Sponsor: Locumstory Learn about locums and get insights from real-life physicians, PAs and NPs at Locumstory.com Sponsor: Panacea Visit panaceafinancial.com and Panacea's Resource Library for free student loan articles, guides, and webinars built to help you make informed decisions. Sponsor: Grammarly  Download Grammarly for free at Grammarly.com/PODCAST

Criticism of JB Pritzker (Governor of Illinois):The speakers argue that Pritzker downplays violent crime in Chicago despite high murder rates. They compare his leadership to officials in Mexico who claim progress while cartels commit violence unchecked. Broader critique of Democrats:Democrats are portrayed as favoring criminals over victims, ignoring rising crime, and pushing policies that weaken law enforcement. The conversation frames them as ideologically extreme and out of touch with public safety concerns. Midterm election outlook (2025):The senator and host discuss Republican opportunities in upcoming elections. They note Democratic fundraising strength but also claim voters are increasingly frustrated with crime and safety issues, which could benefit Republicans. The “Clean DC Act”:The senator introduces legislation to roll back a 2022 D.C. law that reduced penalties for violent crimes. The bill is framed as a test of whether lawmakers side with “criminals or citizens.” Rumors about President Trump’s health:A viral social media claim suggested Trump was dead or incapacitated because he wasn’t seen for a few days. The speakers mock Democrats and the media for allegedly celebrating or hoping it was true. Trump himself is quoted dismissing it as “fake news.” Drug cartels in the U.S.:The conversation highlights a DEA operation in New England that arrested 171 members of the Sinaloa cartel. They emphasize the cartel’s national reach, its trafficking of fentanyl, and the dangers counterfeit pills pose to young people. The epidemic of fentanyl deaths is portrayed as a direct result of “Democratic open border policies.” Military and foreign policy against cartels:The senator describes U.S. military operations in the Caribbean and Central America targeting drug traffickers, including deploying stealth jets and naval ships. He recounts visiting prisons in El Salvador housing violent gang members to illustrate cartel influence in U.S. communities. Please Hit Subscribe to this podcast Right Now. Also Please Subscribe to the 47 Morning Update with Ben Ferguson and The Ben Ferguson Show Podcast Wherever You get You're Podcasts. And don't forget to follow the show on Social Media so you never miss a moment! Thanks for Listening YouTube: https://www.youtube.com/@VerdictwithTedCruz/ Facebook: https://www.facebook.com/verdictwithtedcruz X: https://x.com/tedcruz X: https://x.com/benfergusonshowYouTube: https://www.youtube.com/@VerdictwithTedCruzSee omnystudio.com/listener for privacy information.

Debate on the Source of Rights The episode opens with criticism of Democratic Senator Tim Kaine, who argued in a Senate hearing that constitutional rights come from the government rather than from God. Cruz frames this as a radical departure from America’s founding principles, citing the Declaration of Independence and Thomas Jefferson’s writings. The discussion emphasizes that if rights come from government, they can be taken away, whereas God-given rights are “unalienable.” Religion and the Democratic Party Cruz and Ferguson argue that the Democratic Party is increasingly hostile toward people of faith (Christian, Jewish, Catholic). They highlight responses from religious leaders, including Bishop Robert Barron, who strongly opposed Kaine’s remarks and defended the idea that rights come from God. Border Security and the Cartels The podcast shifts to the issue of border security and drug cartels, especially the Sinaloa cartel. They cite a DEA operation in New England that arrested 171 cartel members in one week, seizing fentanyl and counterfeit pills. Cruz and Ferguson warn about the danger of fentanyl-laced pills, especially for young people, describing it as a national epidemic and the leading cause of death among Americans aged 18–45. U.S. Government Action Against Cartels They discuss U.S. military and DEA efforts to combat cartels, including operations in Mexico, Venezuela, and the Caribbean. Cruz praises the government’s recent designation of cartels as terrorist organizations and the deployment of military assets to fight drug trafficking. Please Hit Subscribe to this podcast Right Now. Also Please Subscribe to the 47 Morning Update with Ben Ferguson and The Ben Ferguson Show Podcast Wherever You get You're Podcasts. And don't forget to follow the show on Social Media so you never miss a moment! Thanks for Listening YouTube: https://www.youtube.com/@VerdictwithTedCruz/ Facebook: https://www.facebook.com/verdictwithtedcruz X: https://x.com/tedcruz X: https://x.com/benfergusonshowYouTube: https://www.youtube.com/@VerdictwithTedCruzSee omnystudio.com/listener for privacy information.

In Part 3 of the Mike Drop Podcast with former DEA agent Wes Tabor, the stakes get higher as Wes recounts his perilous assignment in Venezuela, a narco-terrorist haven under Hugo Chavez's regime. From dodging Cuban and Venezuelan intelligence to operating solo in a hostile environment, Wes shares heart-pounding stories of undercover operations, evading assassination attempts, and targeting high-value cartel members in a lawless "Wild West" of drug trafficking. He also reflects on the personal toll of his 35-year career, the betrayal of corrupt leadership, and the relentless drive that fueled his fight against global crime. This episode is a raw, unfiltered dive into the sacrifices and adrenaline of a DEA agent's life on the edge. Learn more about your ad choices. Visit podcastchoices.com/adchoices

In Part 2 of the gripping Mike Drop Podcast featuring Wes Tabor, a former DEA agent, listeners are taken deeper into the intense world of drug enforcement and high-stakes operations. Wes shares riveting stories from his recovery after a life-altering accident, his relentless pursuit of justice against the odds, and his experiences tackling major cases involving the Sinaloa Cartel and Hezbollah. From confronting criminals in the field to navigating the challenges of corruption within law enforcement, this episode dives into the raw realities of DEA work, including undercover operations, massive cash seizures, and the evolving threat of cryptocurrency in narco-terrorism. Expect unfiltered accounts of danger, sacrifice, and the moral fortitude that defined Wes's career. Tune in for an unflinching look at the front lines of the war on drugs! Learn more about your ad choices. Visit podcastchoices.com/adchoices

Get ready for an unflinching dive into the world of drug enforcement on this episode of the Mike Ritland Podcast, featuring Wes Tabor—a 35-year law enforcement veteran who spent over two decades with the DEA, operating across the United States, Central America, and South America. With stints embedded alongside the CIA and authorship credits for his eye-opening book Infiltrate America (plus the upcoming Beyond Blurry Lines set for next summer), Wes doesn't hold back as he recounts the brutal realities of his career. Mike and Wes dismantle pop culture myths about DEA agents—no, it's not all black fatigues and window-storming raids. Instead, Wes paints a picture of tedious investigations that turn spy-like overseas, while admitting the agency often fails at public messaging, leaving misconceptions about their focus (hint: they weren't chasing small-time weed dealers, but multi-ton shipments of cocaine and heroin from cartels in Venezuela, Colombia, and Mexico). He pulls no punches on DEA leadership, calling out bureaucratic inertia, "latte commandos," and a culture that stifles real change, drawing parallels to issues plaguing the FBI, ATF, and even the military. Tune in for a masterclass in resilience from a guy who's seen it all—and isn't afraid to call it like it is. Learn more about your ad choices. Visit podcastchoices.com/adchoices

The fallout continues over yesterday's tragedy in Minneapolis, the DEA makes a major drug bust in New Hampshire, and Russia continues to hit Ukraine, despite ongoing peace talks. Get the facts first with Evening Wire. Learn more about your ad choices. Visit megaphone.fm/adchoices